Roger Bouillon

Q: What Schools Are Affiliated With Roger Bouillon

Roger Bouillon is affiliated with the following schools: University of California, Berkeley, KU Leuven, University of Tokyo, Stanford University, Tulane University

Roger Bouillon's AcademicInfluence.com Rankings

Roger Bouillon

Physics

#2342

World Rank

#3476

Historical Rank

physics Degrees

Download Badge

Physics

Roger Bouillon's Degrees

PhD Physics University of California, Berkeley
Masters Physics Stanford University

Why Is Roger Bouillon Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Roger Bouillon's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Intensive insulin therapy in critically ill patients. (2001) (6419)
Intensive insulin therapy in the medical ICU. (2006) (2771)
Vitamin D and human health: lessons from vitamin D receptor null mice. (2008) (1606)
An overview of real-time quantitative PCR: applications to quantify cytokine gene expression. (2001) (1432)
Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control* (2003) (1229)
Structure-function relationships in the vitamin D endocrine system. (1995) (1226)
Androgens and bone. (2004) (811)
Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism (2009) (802)
Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. (1990) (705)
Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials. (2007) (554)
Duodenal calcium absorption in vitamin D receptor–knockout mice: Functional and molecular aspects (2001) (547)
“Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study” (2020) (523)
Intensive Insulin Therapy in Mixed Medical/Surgical Intensive Care Units (2006) (500)
Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions (2018) (495)
Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration. (1981) (473)
Muscle force during an acute exacerbation in hospitalised patients with COPD and its relationship with CXCL8 and IGF-I (2003) (465)
Estrogens and Androgens in Skeletal Physiology and Pathophysiology. (2017) (457)
Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene (2009) (452)
Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188 (2000) (441)
Consensus development conference: Prophylaxis and treatment of osteoporosis (2005) (436)
Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3 (1994) (408)
Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. (1997) (400)
Vitamin D and diabetes (2005) (391)
Clinical review 95: Acute and prolonged critical illness as different neuroendocrine paradigms. (1998) (390)
The use of real-time reverse transcriptase PCR for the quantification of cytokine gene expression. (2003) (385)
MANAGEMENT OF ENDOCRINE DISEASE: Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency; a position statement of the European Calcified Tissue Society. (2019) (359)
Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. (2007) (358)
Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus (2016) (337)
Vitamin D: a pleiotropic hormone. (2010) (307)
Tissue‐Type Plasminogen Activator Antigen and Plasminogen Activator Inhibitor in Diabetes Mellitus (1988) (301)
Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization. (2012) (295)
Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. (2006) (288)
Identification and immune regulation of 25‐hydroxyvitamin D‐1‐α‐hydroxylase in murine macrophages (2000) (275)
Bone turnover in prolonged critical illness: effect of vitamin D (2003) (274)
Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival. (2004) (266)
Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. (2013) (266)
Vitamin D and cancer (2006) (262)
Vitamin D and Health: Perspectives From Mice and Man (2008) (253)
Comparative analysis of nutritional guidelines for vitamin D (2017) (248)
Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. (1999) (247)
13th Workshop consensus for vitamin D nutritional guidelines (2007) (246)
1,25-Dihydroxyvitamin D3 Prevents Insulitis in NOD Mice (1992) (243)
Influence of age, sex, and insulin on osteoblast function: osteoblast dysfunction in diabetes mellitus. (1995) (241)
Bone and Mineral Metabolism in BB Rats With Long-Term Diabetes: Decreased Bone Turnover and Osteoporosis (1990) (240)
Vitamin D status in the elderly: seasonal substrate deficiency causes 1,25-dihydroxycholecalciferol deficiency. (1987) (236)
Rationale and Plan for Vitamin D Food Fortification: A Review and Guidance Paper (2018) (234)
C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. (1993) (228)
Bone and mineral metabolism in aged male rats: short and long term effects of androgen deficiency. (1992) (226)
Neuroendocrinology of prolonged critical illness: effects of exogenous thyrotropin-releasing hormone and its combination with growth hormone secretagogues. (1998) (226)
The vitamin D receptor gene FokI polymorphism: Functional impact on the immune system (2007) (226)
Vitamin D nutritional policy needs a vision for the future (2010) (226)
Vitamin D-binding protein (Gc-globulin) binds actin. (1980) (225)
Clinical review: Intensive insulin therapy in critically ill patients: NICE-SUGAR or Leuven blood glucose target? (2009) (225)
Presentation of Hypoparathyroidism: Etiologies and Clinical Features. (2016) (223)
Vitamin D deficiency in early life accelerates Type 1 diabetes in non-obese diabetic mice (2004) (221)
NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization (2003) (211)
Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. (2009) (208)
Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis. (1992) (207)
Immune Regulation of 25‐Hydroxyvitamin‐D3‐1α‐Hydroxylase in Human Monocytes (2005) (206)
Intestinal calcium absorption: Molecular vitamin D mediated mechanisms (2003) (205)
High Doses of Vitamin D to Reduce Exacerbations in Chronic Obstructive Pulmonary Disease (2012) (204)
Intestinal Calcium Transporter Genes Are Upregulated by Estrogens and the Reproductive Cycle Through Vitamin D Receptor‐Independent Mechanisms (2003) (203)
Redirection of human autoreactive T-cells Upon interaction with dendritic cells modulated by TX527, an analog of 1,25 dihydroxyvitamin D(3). (2002) (202)
Active intestinal calcium transport in the absence of transient receptor potential vanilloid type 6 and calbindin-D9k. (2008) (201)
Diabetic bone disease (2007) (200)
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. (2009) (199)
1,25-Dihydroxyvitamin D3 modulates expression of chemokines and cytokines in pancreatic islets: implications for prevention of diabetes in nonobese diabetic mice. (2005) (194)
Mineral and bone metabolism in thyroid disease: a review. (1986) (193)
Estrogens are essential for male pubertal periosteal bone expansion. (2004) (189)
25(OH)D2 Half-Life Is Shorter Than 25(OH)D3 Half-Life and Is Influenced by DBP Concentration and Genotype (2014) (182)
The measurement of the vitamin D-binding protein in human serum. (1977) (180)
Association of hypogonadism with vitamin D status: the European Male Ageing Study. (2012) (178)
Vitamin D assays and the definition of hypovitaminosis D: results from the First International Conference on Controversies in Vitamin D (2018) (178)
Vitamin D Metabolism and Action (1998) (178)
Management of Hypoparathyroidism: Summary Statement and Guidelines. (2016) (177)
1alpha,25-dihydroxyvitamin D3 induces an autoantigen-specific T-helper 1/T-helper 2 immune shift in NOD mice immunized with GAD65 (p524-543). (2000) (174)
Action of 1,25(OH)2D3 on the cell cycle genes, cyclin D1, p21 and p27 in MCF-7 cells (1998) (172)
Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060. (1995) (166)
Fluoride kinetics of the axial skeleton measured in vivo with fluorine-18-fluoride PET. (1997) (165)
Aromatase inhibition impairs skeletal modeling and decreases bone mineral density in growing male rats. (1997) (164)
TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts. (2008) (164)
Differential stimulation of ERK and JNK activities by ultraviolet B irradiation and epidermal growth factor in human keratinocytes. (1997) (164)
Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men (2009) (163)
Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3. (1993) (163)
Relative Impact of Androgen and Estrogen Receptor Activation in the Effects of Androgens on Trabecular and Cortical Bone in Growing Male Mice: A Study in the Androgen Receptor Knockout Mouse Model (2006) (162)
REVIEW ARTICLE: Reducing fracture risk with calcium and vitamin D (2009) (158)
Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites. (2012) (155)
In Vitro and In Vivo Analysis of the Immune System of Vitamin D Receptor Knockout Mice (2001) (155)
The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. (1997) (153)
Comparison of intact, midregion, and carboxy terminal assays of parathyroid hormone for the diagnosis of bone disease in hemodialyzed patients. (1991) (151)
Placental growth factor mediates mesenchymal cell development, cartilage turnover, and bone remodeling during fracture repair. (2006) (151)
Perchlorate versus other environmental sodium/iodide symporter inhibitors: potential thyroid-related health effects. (2006) (150)
Vitamin D: calcium and bone homeostasis during evolution. (2014) (149)
The E2F-regulated gene Chk1 is highly expressed in triple-negative estrogen receptor /progesterone receptor /HER-2 breast carcinomas. (2007) (147)
Clinical Review: Sex steroids and the periosteum--reconsidering the roles of androgens and estrogens in periosteal expansion. (2006) (146)
Thyroid and antithyroid drugs (1988) (144)
Consensus statement from 2nd International Conference on Controversies in Vitamin D (2020) (144)
Thyrotrophin and prolactin release in prolonged critical illness: dynamics of spontaneous secretion and effects of growth hormone‐secretagogues (1997) (142)
Age‐Related (Type II) Femoral Neck Osteoporosis in Men: Biochemical Evidence for Both Hypovitaminosis D– and Androgen Deficiency–Induced Bone Resorption (1997) (140)
Influence of vitamin D on parathyroid function in the elderly. (1992) (139)
Comparison of 6-s-cis- and 6-s-trans-locked analogs of 1alpha,25-dihydroxyvitamin D3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis- nor 6-s-trans-locked analogs are preferred for genomic biological responses. (1997) (139)
Serum 25‐Hydroxyvitamin D Levels: Variability, Knowledge Gaps, and the Concept of a Desirable Range (2015) (138)
Controversies in Vitamin D: Summary Statement From an International Conference (2018) (137)
Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3. (1980) (136)
Free 25-Hydroxyvitamin D: Impact of Vitamin D Binding Protein Assays on Racial-Genotypic Associations (2016) (136)
p38 Mitogen-activated Protein Kinase Regulates a Novel, Caspase-independent Pathway for the Mitochondrial Cytochromec Release in Ultraviolet B Radiation-induced Apoptosis* (2000) (135)
Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system (2004) (134)
Thyroid function in patients with hyperemesis gravidarum. (1982) (133)
Hypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary disease. (2005) (132)
Vitamin D: From Photosynthesis, Metabolism, and action to Clinical Applications (2001) (132)
Measurement of 25-hydroxyvitamin D3 in serum. (1976) (132)
Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor‐α (2009) (131)
1,25‐dihydroxyvitamin D3 inhibits ultraviolet B‐induced apoptosis, Jun kinase activation, and interleukin‐6 production in primary human keratinocytes (2003) (131)
Vitamin D Binding Protein: A Historic Overview (2020) (129)
Immune regulation of 25-hydroxyvitamin-D3-1alpha-hydroxylase in human monocytes. (2006) (129)
Hereditary vitamin D resistant rickets caused by a novel mutation in the vitamin D receptor that results in decreased affinity for hormone and cellular hyporesponsiveness. (1997) (129)
The effect of anticonvulsant therapy on serum levels of 25-hydroxy-vitamin D, calcium, and parathyroid hormone. (1975) (128)
Vitamin D : gene regulation, structure-function analysis, and clinical application : proceedings of the Eighth Workshop on Vitamin D, Paris, France, July 5-10, 1991 (1991) (128)
The combined administration of GH‐releasing peptide‐2 (GHRP‐2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP‐2 alone (2002) (128)
Vitamin D, a pluripotent steroid hormone: structural studies, molecular endocrinology and clinical applications (1994) (128)
Changes in biochemical markers of osteoblastic activity during the menstrual cycle. (1990) (127)
Differential effects on bone of estrogen receptor α and androgen receptor activation in orchidectomized adult male mice (2003) (126)
14th Vitamin D Workshop consensus on vitamin D nutritional guidelines (2010) (126)
TRPV4-mediated calcium influx regulates terminal differentiation of osteoclasts (2008) (125)
Human growth hormone replacement in adult hypopituitary patients: long-term effects on body composition and lipid status--3-year results from the HypoCCS Database. (2002) (123)
Lower vitamin D levels are associated with depression among community-dwelling European men (2011) (123)
Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. (1992) (122)
Vitamin D: do we get enough? (2013) (122)
Bone mineral homeostasis in spontaneously diabetic BB rats. II. Impaired bone turnover and decreased osteocalcin synthesis. (1989) (122)
Prevention of type I diabetes in nonobese diabetic mice by late intervention with nonhypercalcemic analogs of 1,25-dihydroxyvitamin D3 in combination with a short induction course of cyclosporin A. (1998) (121)
Space flight: a challenge for normal bone homeostasis. (2001) (121)
Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo. (2000) (121)
Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study. (2002) (121)
Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma. (2002) (118)
A structural basis for the unique binding features of the human vitamin D-binding protein (2002) (118)
Vitamin D metabolites in captivity? Should we measure free or total 25(OH)D to assess vitamin D status? (2017) (117)
A radioimmunoassay for 1,25-dihydroxycholecalciferol. (1978) (117)
Reduction of blood pressure with oral magnesium supplementation in women with mild to moderate hypertension. (1994) (117)
Comparative study of the affinity of the serum vitamin D-binding protein. (1980) (117)
Microgravity Reduces the Differentiation of Human Osteoblastic MG‐63 Cells (1997) (116)
Vitamin D and diabetes. (2010) (115)
Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants. (2000) (114)
Down‐Regulation of the Serum Stimulatory Components of the Insulin‐like Growth Factor (IGF) System (IGF‐I, IGF‐II, IGF Binding Protein [BP]‐3, and IGFBP‐5) in Age‐Related (Type II) Femoral Neck Osteoporosis (1999) (113)
Vitamin D and SARS-CoV-2 virus/COVID-19 disease (2020) (112)
Vitamin D, parathyroid hormone and the metabolic syndrome in middle-aged and older European men. (2009) (112)
25-HYDROXY-VITAMIN-D IN NEPHROTIC SYNDROME (1977) (111)
Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. (2001) (111)
Vitamin D and energy homeostasis—of mice and men (2014) (110)
The effects of systemic insulin, insulin-like growth factor-I and growth hormone on bone growth and turnover in spontaneously diabetic BB rats. (1992) (109)
Musculoskeletal pain is associated with very low levels of vitamin D in men: results from the European Male Ageing Study (2010) (109)
Mineral Metabolism and Bone Mass at Peripheral and Axial Skeleton in Diabetes Mellitus (1988) (108)
Vitamin D signaling in calcium and bone homeostasis: a delicate balance. (2015) (107)
Prevention of autoimmune destruction of syngeneic islet grafts in spontaneously diabetic nonobese diabetic mice by a combination of a vitamin D3 analog and cyclosporine. (1998) (106)
Bone and mineral metabolism in the androgen‐resistant (testicular feminized) male rat (1993) (106)
Vitamin D analogs with low affinity for the vitamin D binding protein: Enhanced in vitro and decreased in vivo activity (1991) (106)
Parathyroid function in patients with hyper- or hypothyroidism. (1974) (105)
Is calcifediol better than cholecalciferol for vitamin D supplementation? (2018) (105)
Vitamin D and diabetes. (2010) (104)
Immunoradiometric assay of parathyrin with polyclonal and monoclonal region-specific antibodies. (1990) (103)
1,25-Dihydroxyvitamin D3 and analogues protect primary human keratinocytes against UVB-induced DNA damage. (2005) (103)
Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1 α, 25-(OH)2D3 (1995) (99)
Trpv6 mediates intestinal calcium absorption during calcium restriction and contributes to bone homeostasis. (2010) (99)
The purification and characterisation of the human-serum binding protein for the 25-hydroxycholecalciferol (transcalciferin). Identity with group-specific component. (1976) (99)
Two direct (nonchromatographic) assays for 25-hydroxyvitamin D. (1984) (96)
Age‐, gender‐, and weight‐related effects on levels of 25‐hydroxyvitamin D are not mediated by vitamin D binding protein (2007) (95)
The health effects of vitamin D supplementation: evidence from human studies (2021) (94)
The effect of microgravity on morphology and gene expression of osteoblasts in vitro (1999) (94)
Influence of vitamin D status on insulin secretion and glucose tolerance in the rabbit. (1984) (93)
Bone mineral homeostasis in spontaneously diabetic BB rats. I. Abnormal vitamin D metabolism and impaired active intestinal calcium absorption. (1989) (93)
An aged rat model of partial androgen deficiency: prevention of both loss of bone and lean body mass by low-dose androgen replacement (1999) (93)
Mechanism and potential of the growth-inhibitory actions of vitamin D and ana-logs. (2007) (93)
25-hydroxyvitamin D and its binding protein in maternal and cord serum. (1977) (92)
Relationship Between Baseline Insulin‐Like Growth Factor‐I (IGF‐I) and Femoral Bone Density in Women Aged Over 70 Years: Potential Implications for the Prevention of Age‐Related Bone Loss (1996) (92)
The anti-cancer and anti-inflammatory actions of 1,25(OH)₂D₃. (2011) (91)
Analogs of 1α,25‐dihydroxyvitamin D3 as pluripotent immunomodulators (2003) (91)
Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency. (2012) (90)
The Role of the Plasminogen System in Bone Resorption In Vitro (1999) (90)
Evidence From the Aged Orchidectomized Male Rat Model That 17β‐Estradiol Is a More Effective Bone‐Sparing and Anabolic Agent Than 5α‐Dihydrotestosterone (2002) (89)
Evidence From Data Searches and Life‐Table Analyses for Gender‐Related Differences in Absolute Risk of Hip Fracture After Colles' or Spine Fracture: Colles' Fracture as an Early and Sensitive Marker of Skeletal Fragility in White Men (2004) (89)
Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections (2020) (89)
Sunscreen photoprotection and vitamin D status (2019) (89)
Controversies in Vitamin D: A Statement From the Third International Conference (2020) (87)
Does the phosphate binder lanthanum carbonate affect bone in rats with chronic renal failure? (2004) (87)
Immunomodulatory effects of 1,25‐dihydroxyvitamin D3 (1995) (86)
Gene expression related to the differentiation of osteoblastic cells is altered by microgravity. (1998) (85)
Action of androgens versus estrogens in male skeletal homeostasis. (1998) (84)
Primary role of the HLA class II DRB1*0301 allele in Graves disease. (2000) (84)
Effects of short‐term insulin‐like growth factor‐I or growth hormone treatment on bone turnover, renal phosphate reabsorption and 1,25 dihydroxyvitamin D3 production in healthy man (1997) (83)
The Effects of Growth Hormone Replacement Therapy on Bone Metabolism in Adult‐Onset Growth Hormone Deficiency: A 2‐Year Open Randomized Controlled Multicenter Trial (2002) (83)
Role of Assay Type in Determining Free 25-Hydroxyvitamin D Levels in Diverse Populations. (2016) (83)
Chapter 59 – Vitamin D: From Photosynthesis, Metabolism, and Action to Clinical Applications∗ (2016) (83)
Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. (1984) (82)
Osteocalcin during the reproductive cycle in normal and diabetic rats. (1989) (82)
Brittle bones in spontaneously diabetic female rats cannot be predicted by bone mineral measurements: Studies in diabetic and ovariectomized rats (1994) (82)
Skeletal effects of estrogen deficiency as induced by an aromatase inhibitor in an aged male rat model. (2000) (81)
Characterization of gastric antral motility disturbances in diabetes using a scintigraphic technique. (1993) (79)
Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine system. 1,25-dihydroxy-pentadeuterio-previtamin D3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses. (1993) (79)
Testosterone prevents orchidectomy-induced bone loss in estrogen receptor-alpha knockout mice. (2000) (79)
Growth Without Growth Hormone Receptor: Estradiol Is a Major Growth Hormone‐Independent Regulator of Hepatic IGF‐I Synthesis (2005) (79)
Unaltered Diabetes Presentation in NOD Mice Lacking the Vitamin D Receptor (2008) (78)
Growth hormone and bone. (1991) (78)
1,25‐dihydroxyvitamin D3 influences cellular homocysteine levels in murine preosteoblastic MC3T3‐E1 cells by direct regulation of cystathionine β‐synthase (2011) (78)
Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. (2011) (78)
Development of a Method for the Quantification of 1α,25(OH)2–Vitamin D3 in Serum by Liquid Chromatography Tandem Mass Spectrometry without Derivatization (2010) (78)
Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities for vitamin D analogs. (1995) (78)
Partial prevention of active Heymann nephritis by lα, 25 dihydroxyvitamin D3 (1993) (78)
Vitamin D: direct effects of vitamin D metabolites on bone: lessons from genetically modified mice. (2014) (77)
Ultrastructural immunocytochemical localization of endogenous 1,25-dihydroxyvitamin D3 and its receptors in osteoblasts and osteocytes from neonatal mouse and rat calvaria. (1987) (76)
Vitamin D status of elderly people in Spain. (1989) (74)
Binding of 25-hydroxycholecalciferol in tissues. (1977) (73)
The Effects of 1α,25‐Dihydroxyvitamin D3 on the Expression of DNA Replication Genes (2003) (73)
Pituitary responsiveness to GH‐releasing hormone, GH‐releasing peptide‐2 and thyrotrophin‐releasing hormone in critical illness (1996) (72)
Vitamin D Metabolism in Breast-Fed Infants and their Mothers (1989) (72)
Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults. (1998) (72)
Immune Regulation of 25-Hydroxyvitamin D-1α-Hydroxylase in Human Monocytic THP1 Cells: Mechanisms of Interferon-γ-Mediated Induction (2006) (71)
Impact of Androgens, Growth Hormone, and IGF‐I on Bone and Muscle in Male Mice During Puberty (2006) (71)
Homologous radioimmunoassay of human osteocalcin. (1992) (70)
Altered parathyroid set point to calcium in familial hypocalciuric hypercalcaemia. (1984) (70)
Cortisol response to critical illness: effect of intensive insulin therapy. (2006) (70)
Effect of motilin on gastric emptying in patients with diabetic gastroparesis. (1992) (68)
Vitamin D insufficiency: Definition, diagnosis and management. (2018) (68)
VDR‐dependent regulation of mast cell maturation mediated by 1,25‐dihydroxyvitamin D3 (2007) (68)
Age-Associated Decline in Human Femoral Neck Cortical and Trabecular Content of Insulin-Like Growth Factor I: Potential Implications for Age-Related (Type II) Osteoporotic Fracture Occurrence (1997) (68)
Combination of a 1,25-dihydroxyvitamin D3 analog and a bisphosphonate prevents experimental autoimmune encephalomyelitis and preserves bone. (2003) (66)
Superagonistic Action of 14-epi-Analogs of 1,25-Dihydroxyvitamin D Explained by Vitamin D Receptor-Coactivator Interaction (2005) (66)
Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology. (2009) (65)
Increased Bone Formation in Mice Lacking Plasminogen Activators (2003) (65)
Role of the Androgen Receptor in Skeletal Homeostasis: The Androgen‐Resistant Testicular Feminized Male Mouse Model (2004) (65)
Mice Lacking the Plasminogen Activator Inhibitor 1 Are Protected from Trabecular Bone Loss Induced by Estrogen Deficiency (2000) (65)
Time-related increase of biochemical markers of bone turnover in androgen-deficient male rats. (1994) (64)
Effects of recombinant human growth hormone and insulin‐like growth factor‐I, with or without 17β‐estradiol, on bone and mineral homeostasis of aged ovariectomized rats (1996) (63)
Defect in activation-induced cell death in non-obese diabetic (NOD) T lymphocytes. (2003) (63)
Insulin-like Growth Factor-1-mediated AKT Activation Postpones the Onset of Ultraviolet B-induced Apoptosis, Providing More Time for Cyclobutane Thymine Dimer Removal in Primary Human Keratinocytes* (2002) (63)
Disorders of calcium homeostasis. (2003) (62)
Endocrine determinants of incident sarcopenia in middle-aged and elderly European men (2015) (62)
Prevalence and incidence of diabetes mellitus in adult patients on growth hormone replacement for growth hormone deficiency: a surveillance database analysis. (2011) (61)
Vitamin D metabolites in childhood nephrotic syndrome (2005) (61)
Determination of Free 25(OH)D Concentrations and Their Relationships to Total 25(OH)D in Multiple Clinical Populations (2018) (61)
The impact of 1,25(OH)2D3 and its structural analogs on gene expression in cancer cells--a microarray approach. (2009) (60)
Novel insights in the immune function of the vitamin D system: Synergism with interferon-beta (2007) (58)
Early graft failure of xenogeneic islets in NOD mice is accompanied by high levels of interleukin-1 and low levels of transforming growth factor-beta mRNA in the grafts. (2000) (58)
The Biological Activity of Nonsteroidal Vitamin D Hormone Analogs Lacking Both the C‐ and D‐Rings (1998) (57)
Calcifediol Treatment and Hospital Mortality Due to COVID-19: A Cohort Study (2021) (57)
A homozygous inactivating calcium‐sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia (2010) (57)
Calcifediol treatment and COVID-19-related outcomes (2021) (56)
Increases in calbindin D 28K mRNA in the uterus of the domestic fowl induced by sexual maturity and shell formation. (1989) (56)
Measurement of vitamin D and its metabolites (calcidiol and calcitriol) and their clinical significance. (1997) (56)
Genetic and environmental determinants of vitamin D status (2010) (55)
Vitamin D and regulation of gene expression. (1998) (55)
Bone status and fracture prevalence in Russian adults with childhood-onset growth hormone deficiency. (2004) (54)
Vitamin D Metabolism Revised: Fall of Dogmas (2019) (53)
Five‐year follow‐up of growth hormone antibodies in growth hormone deficient children treated with recombinant human growth hormone (1993) (53)
[Vitamin D and human health]. (2019) (53)
Effects of exercise and disuse on bone remodeling, bone mass, and biomechanical competence in spontaneously diabetic female rats. (2000) (53)
Retinoic acid modulates the anti-proliferative effect of 1,25-dihydroxyvitamin D3 in cultured human epidermal keratinocytes. (1997) (53)
Extra-Skeletal Effects of Vitamin D. (2018) (53)
Mechanisms for the selective action of Vitamin D analogs (2005) (51)
Polyunsaturated fatty acids decrease the apparent affinity of vitamin D metabolites for human vitamin D-binding protein (1992) (51)
Influence of dialysate calcium concentration and vitamin D on serum parathyroid hormone during repetitive dialysis. (1975) (51)
Resorptive versus absorptive hypercalciuria in sarcoidosis: correlations with 25-hydroxy vitamin D3 and 1,25-dihydroxy vitamin D3 and parameters of disease activity. (1985) (51)
Mechanisms Influencing Bone Metabolism in Chronic Illness (2002) (50)
Non-hypercalcemic pharmacological aspects of vitamin D analogs. (1995) (50)
Anti-placental growth factor reduces bone metastasis by blocking tumor cell engraftment and osteoclast differentiation. (2010) (50)
A comparison between the diagnostic value of gonadotropins, alpha-subunit, and chromogranin-A and their response to thyrotropin-releasing hormone in clinically nonfunctioning, alpha-subunit-secreting, and gonadotroph pituitary adenomas. (1993) (50)
Calcitriol Improves Streptozotocin-induced Diabetes and Recovers Bone Mineral Density in Diabetic Rats (2004) (49)
Calciotropic hormones during reproduction (1992) (49)
New insights into the role of vitamin D and calcium in osteoporosis management: an expert roundtable discussion (2008) (49)
Pancreatic secretion in man with subclinical vitamin D deficiency (2006) (49)
Biological Activity of CD‐Ring Modified 1α,25‐Dihydroxyvitamin D Analogues: C‐Ring and Five‐Membered D‐Ring Analogues (2000) (49)
Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness. (1999) (48)
Role of group-specific component (vitamin D binding protein) in clearance of actin from the circulation in the rabbit. (1988) (48)
Etiology of hypercalcemia in a patient with Addison's disease (2006) (48)
Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study. (2015) (48)
Treatment of autoimmune diabetes recurrence in non‐obese diabetic mice by mouse interferon‐β in combination with an analogue of 1α,25‐dihydroxyvitamin‐D3 (2002) (47)
Vitamin D Metabolites and Their Binding Protein in Adult Diabetic Patients (1986) (47)
Differing shapes of 1α,25-dihydroxyvitamin D3 function as ligands for the D-binding protein, nuclear receptor and membrane receptor: A status report (1996) (47)
Molecular pathways involved in the anti‐apoptotic effect of 1,25‐dihydroxyvitamin D3 in primary human keratinocytes (2004) (47)
NOD macrophages produce high levels of inflammatory cytokines upon encounter of apoptotic or necrotic cells. (2004) (47)
Relationship between age-associated endocrine deficiencies and muscle function in elderly women: a cross-sectional study. (1998) (47)
Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved. (1997) (46)
1,25-Dihydroxyvitamin D and vitamin D-binding protein are both decreased in streptozotocin-diabetic rats. (1985) (46)
Characterization of the Condensin Component Cnap1 and Protein Kinase Melk as Novel E2F Target Genes Down-regulated by 1,25-Dihydroxyvitamin D3* (2005) (46)
New insights into the role of vitamin D and calcium in osteoporosis management: an expert roundtable discussion. (2008) (45)
Immune regulation of 1α-hydroxylase in murine peritoneal macrophages: Unravelling the IFNγ pathway (2007) (45)
Vitamin D-binding protein and vitamin D in blacks and whites. (2014) (45)
Sex difference in resistance to dexamethasone-induced apoptosis in NOD mice: treatment with 1,25(OH)2D3 restores defect. (1998) (44)
Synergism between sirolimus and 1,25-dihydroxyvitamin D3 in vitro and in vivo (1997) (44)
Vitamin D, mitochondria, and muscle. (2013) (43)
Hyperparathyroidism and abnormal calcitriol metabolism in the spontaneously hypertensive rat. (1989) (43)
Vitamin D in thyroid tumorigenesis and development. (2013) (43)
Immunochemical measurement of the vitamin D-binding protein in rat serum. (1978) (43)
Seasonality of birth in patients with type 1 diabetes (2002) (43)
Expression of the BRCA1-interacting protein Brip1/BACH1/FANCJ is driven by E2F and correlates with human breast cancer malignancy (2008) (42)
PDLIM2 expression is driven by vitamin D and is involved in the pro-adhesion, and anti-migration and -invasion activity of vitamin D (2014) (42)
Estimation of thyroid gland volume by spiral computed tomography (1997) (42)
Superagonistic fluorinated vitamin D3 analogs stabilize helix 12 of the vitamin D receptor. (2008) (42)
The isolation and characterization of the vitamin D-binding protein from rat serum. (1978) (42)
Free or Total 25OHD as Marker for Vitamin D Status? (2016) (42)
Growth Hormone and Bone Health (2003) (41)
Predictors of 25(OH)D half-life and plasma 25(OH)D concentration in The Gambia and the UK (2014) (41)
Analogs of 1alpha,25-dihydroxyvitamin D3 as pluripotent immunomodulators. (2003) (41)
Decreased free 1,25-dihydroxycholecalciferol index in patients with the nephrotic syndrome. (1986) (41)
T lymphocytes and their CD4 subset are direct targets for the inhibitory effect of calcitriol. (1989) (41)
Dynamics of growth hormone secretion in patients with osteoporosis and in patients with osteoarthrosis. (1982) (40)
Bone and Metabolism: A Complex Crosstalk (2009) (40)
The effects of chronic vitamin D deficiency on the skeleton in the adult rabbit. (1988) (40)
Primary hyperparathyroidism: diagnosis and management in the older individual. (2004) (40)
The effect of vitamin D analogs and of vitamin D-binding protein on lymphocyte proliferation. (1988) (40)
Immune regulation of 1alpha-hydroxylase in murine peritoneal macrophages: unravelling the IFNgamma pathway. (2007) (40)
GNAS defects identified by stimulatory G protein alpha-subunit signalling studies in platelets. (2008) (40)
Pregnancy in Mice Lacking the Vitamin D Receptor: Normal Maternal Skeletal Response, But Fetal Hypomineralization Rescued by Maternal Calcium Supplementation (2003) (39)
The Impact of congenital, severe, untreated growth hormone (GH) deficiency on bone size and density in young adults: insights from genetic GH-releasing hormone receptor deficiency. (2003) (39)
Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone. (1998) (39)
Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort study. (2015) (39)
NOD bone marrow-derived dendritic cells are modulated by analogs of 1,25-dihydroxyvitamin D3 (2004) (39)
Androgens and the skeleton. (2005) (39)
Serum levels of growth hormone‐binding protein and insulin‐like growth factor‐I during puberty * (1992) (39)
Enhancement of antiproliferative activity of 1α,25-dihydroxyvitamin D3 (analogs) by cytochrome P450 enzyme inhibitors is compound- and cell-type specific (1996) (39)
1,25-Dihydroxyvitamin D3 and the aging-related Forkhead Box O and Sestrin proteins in osteoblasts (2013) (38)
Propofol Anesthesia Does Not Inhibit Stimulation of Cortisol Synthesis (1995) (38)
Growth hormone and the steroid binding -globulin of human plasma. (1972) (38)
Rickets due to dietary calcium deficiency (1989) (38)
Androgens and bone (1995) (37)
Osteoporosis and diabetes: lessons from the diabetic BB rat. (1990) (37)
Effects of short-term growth hormone treatment on PTH, calcitriol, thyroid hormones, insulin and glucagon. (1992) (37)
The diagnosis and treatment of male osteoporosis: Defining, assessing, and preventing skeletal fragility in men. (2007) (37)
Prevention and consequences of vitamin D deficiency in pregnant and lactating women and children: A symposium to prioritise vitamin D on the global agenda (2016) (37)
High Dose Vitamin D supplementation alters faecal microbiome and predisposes mice to more severe colitis (2018) (37)
Genetic and Racial Differences in the Vitamin D Endocrine System. (2017) (36)
Acute adrenal insufficiency. (2006) (36)
The Vitamin D Binding Protein DBP (2011) (35)
Prevention of autoimmune destruction of transplanted islets in spontaneously diabetic NOD mice by KH1060, a 20-epi analog of vitamin D: synergy with cyclosporine. (1994) (35)
Disappearance of vascular calcifications during treatment of renal osteodystrophy. Two patients treated with high doses of vitamin D and aluminum hydroxide. (1975) (35)
Calcium, vitamin D-endocrine system, and parathyroid hormone in black and white males (1987) (35)
Two 14-epi analogues of 1,25-dihydroxyvitamin D3 protect human keratinocytes against the effects of UVB (2004) (35)
Ageing and calcium metabolism. (1997) (35)
Physical activity in the androgen receptor knockout mouse: evidence for reversal of androgen deficiency on cancellous bone. (2009) (35)
The effect of trauma on serum concentrations of vitamin D metabolites in patients with hip fracture. (1985) (35)
Immune regulation of 25-hydroxyvitamin D-1alpha-hydroxylase in human monocytic THP1 cells: mechanisms of interferon-gamma-mediated induction. (2006) (35)
1,25-Dihydroxyvitamin D3 and a superagonistic analog in combination with paclitaxel or suberoylanilide hydroxamic acid have potent antiproliferative effects on anaplastic thyroid cancer (2011) (34)
Ageing of bone: its relation to osteoporosis and osteoarthrosis in post-menopausal women. (1975) (34)
Syndrome of lipoatrophic diabetes, vitamin D resistant rickets, and persistent Müllerian ducts in a Turkish boy born to consanguineous parents. (1996) (34)
Vitamin D action: lessons from VDR and Cyp27b1 null mice. (2013) (33)
Relief of sleep apnoea after treatment of acromegaly: report of three cases and review of the literature. (1997) (33)
Decreased osteoblast activity in spontaneously diabetic rats (1997) (33)
Vitamin D and bone mineral homeostasis during pregnancy in the diabetic BB rat. (1986) (33)
Recent developments in the use of vitamin D analogues (1998) (33)
Vitamin D receptor expression is linked to cell cycle control in normal human keratinocytes. (2000) (33)
A novel nonsense mutation in the ligand binding domain of the vitamin D receptor causes hereditary 1,25-dihydroxyvitamin D-resistant rickets. (2002) (32)
Structure function analysis of vitamin D analogs with C-ring modifications. (1992) (32)
A structural basis for the unique binding features of the human vitamin D-binding protein (2002) (32)
Recent developments in the use of vitamin D analogues (2000) (32)
Differentiation induction of human leukemia cells (HL60) by a combination of 1,25-dihydroxyvitamin D3 and retinoic acid (all trans or 9-cis) (1995) (32)
Associations of total and free 25OHD and 1,25(OH)2D with serum markers of inflammation in older men (2016) (32)
Biologic activity of dihydroxylated 19‐nor‐(pre)vitamin D3 (1993) (32)
Actin-DBP: the perfect structural fit? (2003) (32)
Calciotropic hormones and markers of bone remodeling in age-related (type II) femoral neck osteoporosis: alterations consistent with secondary hyperparathyroidism-induced bone resorption. (1997) (32)
1,25-Dihydroxyvitamin D3 reduces MHC antigen expression on pancreatic beta-cells in vitro. (1997) (31)
Microarray analysis of 1α,25-dihydroxyvitamin D3-treated MC3T3-E1 cells (2004) (31)
1Alpha,25-dihydroxyvitamin D3 restores thymocyte apoptosis sensitivity in non-obese diabetic (NOD) mice through dendritic cells. (2005) (31)
Vitamin D and cardiovascular disorders (2019) (31)
Ultraviolet B suppresses vitamin D receptor gene expression in keratinocytes. (1998) (31)
Physiological functions of vitamin D: what we have learned from global and conditional VDR knockout mouse studies. (2015) (31)
Osteoporosis and osteoporotic fractures in men: a clinical perspective. (2000) (31)
Radiochemical assays for vitamin D metabolites: technical possibilities and clinical applications. (1983) (31)
Bone and mineral metabolism in the adult guinea pig: Long‐term effects of estrogen and androgen deficiency (1992) (31)
Associations of 25‐Hydroxyvitamin D and 1,25‐Dihydroxyvitamin D With Bone Mineral Density, Bone Mineral Density Change, and Incident Nonvertebral Fracture (2015) (31)
Dual role of interferon-γ signalling pathway in sensitivity of pancreatic beta cells to immune destruction (2001) (31)
Synthesis, biological activity, and conformational analysis of four seco-D-15,19-bisnor-1alpha,25-dihydroxyvitamin D analogues, diastereomeric at C17 and C20. (1999) (31)
Vitamin D : chemistry, biology and clinical applications of the steroid hormone : proceedings of the Tenth Workshop on Vitamin D, Strasbourg, France, May 24-29, 1997 (1997) (31)
Bone and muscle protective potential of the prostate-sparing synthetic androgen 7alpha-methyl-19-nortestosterone: evidence from the aged orchidectomized male rat model. (2005) (31)
Vitamin D endocrine system : structural, biological, genetic and clinical aspects : proceedings of the Eleventh Workshop on Vitamin D, Nashville, Tennessee, USA, May 27-June 1, 2000 (2000) (31)
Dermal fibroblasts pretreated with a sterol Delta7-reductase inhibitor produce 25-hydroxyvitamin D3 upon UVB irradiation. (2006) (31)
Diabetic bone disease. Low turnover osteoporosis related to decreased IGF-I production. (1992) (30)
Low vitamin D and the risk of developing chronic widespread pain: results from the European male ageing study (2014) (30)
Synthesis, biological activity, and conformational analysis of CD-ring modified trans-decalin 1 alpha,25-dihydroxyvitamin D analogs. (2003) (30)
Serum chromogranin A in the differential diagnosis of Cushing's syndrome. (1994) (30)
Serum levels of growth hormone-binding protein and insulin-like growth factor I in children and adolescents with Type 1 (insulin-dependent) diabetes mellitus (1993) (30)
Serum growth hormone (GH)-binding protein and insulin-like growth factor-I levels in Turner's syndrome before and during treatment with recombinant human GH and ethinyl estradiol. (1992) (30)
Deficiency of the growth hormone-insulin-like growth factor-I axis potentially involved in age-related alterations in body composition. (1996) (30)
Age-associated endocrine deficiencies as potential determinants of femoral neck (type II) osteoporotic fracture occurrence in elderly men. (1997) (30)
Effects of sex steroids on hepatic and lipoprotein lipase activity and mRNA in the rat. (1993) (29)
A thyroid thriller: acute transient and symmetric goiter after fine-needle aspiration of a solitary thyroid nodule. (2008) (29)
The isolation and characterization of the 25-hydroxyvitamin D-binding protein from chick serum. (1980) (29)
Vitamin D Deficiency in Guinea Pigs: Exacerbation of Bone Phenotype During Pregnancy and Disturbed Fetal Mineralization, with Recovery by 1,25(OH)2D3 Infusion or Dietary Calcium-Phosphate Supplementation (2002) (29)
Seasonal variation in bone metabolism in young healthy subjects (1991) (29)
Androgen resistance and deficiency have different effects on the growing skeleton of the rat (1994) (29)
Higher 25(OH)D2 is associated with lower 25(OH)D3 and 1,25(OH)2D3. (2014) (29)
UVB‐induced production of 1,25‐dihydroxyvitamin D3 and vitamin D activity in human keratinocytes pretreated with a sterol Δ7‐reductase inhibitor (2006) (29)
Vitamin D deficiency. (2007) (29)
The heterogeneity of human Gc-globulin. (1978) (28)
Vitamin D: Dosing, levels, form, and route of administration: Does one approach fit all? (2021) (28)
Umbilical cord osteocalcin in normal pregnancies and pregnancies complicated by fetal growth retardation or diabetes mellitus. (1995) (28)
Interaction of Two Novel 14‐Epivitamin D3 Analogs with Vitamin D3 Receptor‐Retinoid X Receptor Heterodimers on Vitamin D3 Responsive Elements (2001) (28)
Maternal and fetal endocrine pancreas in the spontaneously diabetic BB rat. (1989) (27)
Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF 23 production in osteoblasts (2006) (27)
Vitamin D supplementation in respiratory diseases: evidence from randomized controlled trials. (2017) (27)
Why modest but widespread improvement of the vitamin D status is the best strategy? (2011) (27)
Decreased osteoblast activity in spontaneously diabetic rats. In vivo studies on the pathogenesis. (1997) (27)
Effects of long-term diabetes and/or high-dose 17β-estradiol on bone formation, bone mineral density, and strenght in ovariectomized rats (1997) (26)
Neuroendocrine tumor markers and enterochromaffin-like cell hyper/dysplasia in type 1 diabetes. (2004) (26)
Lymphocytic infundibulohypophysitis presenting in the postpartum period: case report. (1996) (26)
Calcium metabolism, plasma parathyroid hormone, and calcitriol in transient hypertension of pregnancy. (1993) (26)
1 Alpha,25-dihydroxyvitamin D3 and its TX527 analog inhibit the growth of endothelial cells transformed by Kaposi sarcoma-associated herpes virus G protein-coupled receptor in vitro and in vivo. (2010) (26)
Synthesis of CD-ring modified 1α,25-dihydroxy vitamin D analogues : E-ring analogues (1996) (26)
A combination of KH1060, a vitamin D(3) analogue, and cyclosporin prevents early graft failure and prolongs graft survival of xenogeneic islets in nonobese diabetic mice. (2001) (25)
A new approach to imprinting mutation detection in GNAS by Sequenom EpiTYPER system. (2010) (25)
Clinical applications for vitamin D assays: what is known and what is wished for. (2011) (25)
The aged male rat as a model for human osteoporosis: Evaluation by nondestructive measurements and biomechanical testing (1993) (25)
NIH deltanoids meeting on Vitamin D and cancer Conclusion and strategic options (2005) (25)
The nature of opioid involvement in the hemodynamic respiratory and humoral responses to exercise. (1985) (25)
Acute shock induced by antigen vaccination in NOD mice. (2003) (25)
Increased clearance of 1,25(OH)2D3 and tissue-specific responsiveness to 1,25(OH)2D3 in diabetic rats. (1993) (24)
Coexistence of hypocalciuric hypercalcaemia and interstitial lung disease in a family: a cross‐sectional study (1985) (24)
Potential role of 1,25(OH)2 vitamin D3 as a dose-reducing agent for cyclosporine and FK 506. (1994) (24)
The prevention or treatment of age‐related osteoporosis in the elderly by systemic recombinant growth factor therapy (rhIGF‐I or rhTGFβ): a perspective (1997) (24)
New Aspects of the Plasma Carrier Protein for 25‐Hydroxycholecalciferol in Vertebrates (1988) (24)
Hormonal and volumetric long term control of a growth hormone-releasing hormone-producing carcinoid tumor. (1999) (23)
MAGNESIUM ADMINISTRATION REVERSES THE HYPOCALCAEMIA SECONDARY TO HYPOMAGNESAEMIA DESPITE LOW CIRCULATING LEVELS OF 25‐HYDROXYVITAMIN D AND 1,25‐DIHYDROXY VITAMIN D (1985) (23)
AKT status controls susceptibility of malignant keratinocytes to the early-activated and UVB-induced apoptotic pathway. (2004) (23)
The Estrogen Receptor Ligand ICI 182,780 Does Not Impair the Bone-Sparing Effects of Testosterone in the Young Orchidectomized Rat Model (2002) (23)
Evidence for an interaction of insulin and sex steroids in the regulation of vitamin D metabolism in the rat. (1987) (23)
Increased plasma concentrations of total and free 1,25-(OH)2D3 in calcium stone formers with idiopathic hypercalciuria. (1987) (23)
The measurement of fecal thyroxine in the diagnosis of thyrotoxicosis factitia. (1993) (23)
Photoaffinity labeling of human serum vitamin D binding protein and chemical cleavages of the labeled protein: identification of an 11.5-kDa peptide containing the putative 25-hydroxyvitamin D3 binding site. (1991) (22)
Real world evidence of calcifediol or vitamin D prescription and mortality rate of COVID-19 in a retrospective cohort of hospitalized Andalusian patients (2021) (22)
Growth Hormone Deficiency and Peak Bone Mass (2000) (22)
Emergencies of Calcium Homeostasis (2003) (22)
Anchorage-dependent expression of the vitamin D receptor in normal human keratinocytes. (1998) (22)
Interactions of insulin-like growth factor I with dexamethasone on trabecular bone density and mineral metabolism in rats. (1994) (22)
Vitamin D status in Africa is worse than in other continents. (2019) (22)
1,25(OH)2D3 and Ca-binding protein in fetal rats: relationship to the maternal vitamin D status. (1988) (22)
1α,25-Dihydroxyvitamin D3-induced down-regulation of the checkpoint proteins, Chk1 and Claspin, is mediated by the pocket proteins p107 and p130 (2007) (21)
Aromatization of androgens is important for skeletal maintenance of aged male rats (1996) (21)
Vitamin D as potential baseline therapy for blood pressure control. (2009) (21)
Activated form of vitamin D [1,25(OH)2D3] and its analogs are dose-reducing agents for cyclosporine in vitro and in vivo. (1994) (21)
Prospects for vitamin D receptor modulators as candidate drugs for cancer and (auto)immune diseases. (2003) (21)
UVB‐induced 1,25(OH)2D3 production and vitamin D activity in intestinal CaCo‐2 cells and in THP‐1 macrophages pretreated with a sterol Δ7‐reductase inhibitor (2006) (21)
Nutritional rickets: Historic overview and plan for worldwide eradication (2019) (21)
Attenuated rise of 1,25 (OH)2 vitamin D3 in response to parathyroid hormone in patients with incipient renal failure. (1991) (21)
Group-specific component. Report on the First International Workshop, Paris (1979) (20)
Duodenal calcium absorption in dexamethasone-treated mice: functional and molecular aspects. (2007) (20)
Pathogenesis of Fetal Hypomineralization in Diabetic Rats: Evidence for Delayed Bone Maturation (1999) (20)
Hypogonadism in male outpatients with sarcoidosis. (2007) (20)
Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial (2021) (20)
Parathyroid hormone secretion in primary hyperparathyroidism. (1977) (20)
Diabetes and other endocrine disorders during pregnancy and in the newborn (1979) (20)
Forkhead box O transcription factors in chondrocytes regulate endochondral bone formation (2016) (19)
Ascorbate Increases the 1,25 Dihydroxyvitamin D3-Induced Monocytic Differentiation of HL-60 Cells (1996) (19)
Three-dimensional structure-function relationship of vitamin D: side chain location and various activities. (1999) (19)
Prevention of type I diabetes by late intervention with nonhypercalcemic analogues of vitamin D3 in combination with cyclosporin A. (1996) (19)
5-Hydroxytryptamine-1 receptor activation inhibits endocrine pancreatic secretion in humans. (1998) (19)
Pathophysiological data obtained with a radioimmunoassay for human parathyroid hormone. (1973) (19)
Growth hormone should be used only for approved indications. (2014) (19)
Different Mechanisms of Hypercalciuria in Sarcoidosis (1986) (18)
Prevention of type I diabetes in NOD mice by 1,25- dihydroxyvitamin D 3 and its analog (1994) (18)
Prevention of diabetes recurrence after syngeneic islet transplantation in NOD mice by analogues of 1,25(OH)2D3 in combination with cyclosporin A: mechanism of action involves an immune shift from Th1 to Th2. (1998) (18)
Occult ectopic ACTH secretion due to recurrent lung carcinoid: long‐term control of hypercortisolism by continuous subcutaneous infusion of octreotide (1998) (18)
Rat diaphragm contractility and histopathology are affected differently by low dose treatment with methylprednisolone and deflazacort. (1995) (18)
Synthesis of spiro[4.5]decane CF-ring analogues of 1 alpha,25-dihydroxyvitamin D3. (2006) (18)
Diabetes and low Ca-P diet have opposite effects on adult and fetal bone mineral metabolism. (1988) (18)
Differentiation induction of HL60 cells by 1,25(OH)2D3, all trans retinoic acid, rTGF-β 2 and their combinations (1997) (18)
Regulation of 25-hydroxyvitamin d-1α-hydroxylase by IFNγ in human monocytic THP1 cells (2004) (18)
Heterogeneity of human growth hormone in serum. (1974) (18)
p38 Mitogen-activated Protein Kinase Regulates a Novel, Caspase-independent Pathway for the Mitochondrial Cytochrome c Release in Ultraviolet B Radiation-induced Apoptosis* (2000) (18)
Regulation of 25-hydroxyvitamin d-1alpha-hydroxylase by IFNgamma in human monocytic THP1 cells. (2004) (18)
The Vitamin D Receptor in Thyroid Development and Function (2012) (17)
The synthesis of CD - ring modified 1α,25-dihydroxy vitamin D analogues: Six-membered D-ring analogues II (1997) (17)
Vitamin D receptor and vitamin D action in muscle. (2014) (17)
IN MIDDLE-AGED AND OLDER EUROPEAN MEN (2009) (17)
Vitamin D analogs and coactivators. (2006) (17)
Transport of vitamin D: Significance of free and total concentrations of the vitamin D metabolites (2006) (17)
[Immune modulation by vitamin D analogs in the prevention of autoimmune diseases]. (1995) (17)
Vitamin D deficiency in the elderly (1991) (17)
Suppression of vitamin D receptor and induction of retinoid X receptor alpha expression during squamous differentiation of cultured keratinocytes. (2000) (17)
1,25-Dihydroxyvitamin D3 and osteocalcin in maternal and fetal guinea pigs. (1994) (17)
Ontogeny and oestradiol dependence of vitamin D-binding protein blood levels in chickens. (1986) (16)
The transport of vitamin D in the serum of primates. (1976) (16)
The flavonoid apigenin suppresses vitamin D receptor expression and vitamin D responsiveness in normal human keratinocytes. (2000) (16)
Regulation of calbindin D 28K and its mRNA in the intestine of the domestic hen. (1992) (16)
Calcium Regulating Hormones, Vitamin D Metabolites, and Cyclic AMP Assays and Their Clinical Application (1990) (16)
Treatment of autoimmune diabetes recurrence in non-obese diabetic mice by mouse interferon-beta in combination with an analogue of 1alpha,25-dihydroxyvitamin-D3. (2002) (16)
THE TRANSPORT OF VITAMIN D (1980) (16)
[Quality of induction and adrenocortical function. A clinical comparison of Etomidate-Lipuro and Hypnomidate]. (1993) (16)
Synthesis of CD-ring modified 1alpha,25-dihydroxy vitamin D analogues: C-ring analogues (1996) (16)
Nonhypercalcemic vitamin D analogs: interactions with the vitamin D-binding protein. (1996) (16)
Optimal control of glycemia among critically ill patients. (2004) (16)
Development of analogues of 1alpha,25-dihydroxyvitamin D3 with biased side chain orientation: methylated des-C,D-homo analogues. (2001) (15)
Glucose control in critically ill patients. (2009) (15)
The vitamin D hormone and its nuclear receptor: genomic mechanisms involved in bone biology (1999) (15)
Possible association of CD3 and CD4 polymorphisms with insulin‐dependent diabetes mellitus (IDDM) (1994) (15)
The somatotrophic axis in critical illness: effects of growth hormone secretagogues. (1998) (15)
5-Hydroxytryptamine-1 receptor activation inhibits endocrine pancreatic secretion in humans. (1998) (15)
Previtamin D3 with a trans-Fused Decalin CD-ring Has Pronounced Genomic Activity* (2003) (15)
Is Vitamin D2 Really Bioequivalent to Vitamin D3? (2016) (14)
Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1α,25-dihydroxyvitamin D3: spiro[5.5]undecane CF-ring analogues (2004) (14)
Altered Vitamin D receptor–coactivator interactions reflect superagonism of Vitamin D analogs (2005) (14)
Presence of immunoreactive vitamin D-binding protein in rat yolk sac endodermal cells. (1985) (14)
Vitamin D insufficiency as a determinant of hip fractures (2005) (14)
CD-ring modified vitamin D3 analogs and their superagonistic action (2010) (14)
1β,25-Dihydroxyvitamin D3: A new vitamin D metabolite in human serum (2017) (14)
Epidermal keratinocytes as source and target cells for vitamin D (abstract) (2000) (14)
IMMUNOLOGICAL AND CLINICAL OBSERVATIONS IN DIABETIC KIDNEY GRAFT RECIPIENTS PRETREATED WITH TOTAL‐LYMPHOID IRRADIATION (1987) (14)
Synthesis of 25-hydroxyvitamin D3 3 beta-3'-[N-(4-azido-2-nitrophenyl)amino]propyl ether, a second-generation photoaffinity analogue of 25-hydroxyvitamin D3: photoaffinity labeling of rat serum vitamin D binding protein. (1991) (14)
Particles from dialysis tubing stimulate interleukin-1 secretion by macrophages. (1990) (14)
Effects of long-term diabetes and/or high-dose 17 beta-estradiol on bone formation, bone mineral density, and strength in ovariectomized rats. (1997) (14)
Normalization of decreased plasma concentrations of growth hormone-binding protein by insulin treatment in spontaneously diabetic BB rats. (1993) (14)
Microarray analysis of 1alpha,25-dihydroxyvitamin D3-treated MC3T3-E1 cells. (2004) (13)
The many faces of rickets. (1998) (13)
Prevention of hyperparathyroidism in patients on maintenance dialysis by intravenous 1-alpha-hydroxyvitamin D3 in association with Mg(OH)2 as sole phosphate binder. A randomized comparative study with the association CaCO3 +/- Mg(OH)2. (1992) (13)
Vitamin D3: synthesis of seco C-9,11,21-trisnor-17-methyl-1α, 25-dihydroxyvitamin D3 analogues (2002) (13)
Vitamin D Endocrine System and COVID-19: Treatment with Calcifediol (2022) (13)
Optimal range of plasma concentration of true 1-84 parathyroid hormone in patients on maintenance dialysis. (2001) (13)
The development of CD-ring modified analogs of 1α,25-dihydroxyvitamin D (2007) (13)
Parathyroid function in primary osteoporosis. (1979) (13)
Vitamin D Supplementation and Fractures in Adults: A Systematic Umbrella Review of Meta-Analyses of Controlled Trials (2021) (13)
Recombinant human interleukin-11 does not modify biochemical parameters of bone remodeling and bone mineral density in adult ovariectomized rats. (1998) (13)
Vitamin D resistance. (2006) (13)
Effects of opioid antagonism on the haemodynamic and hormonal responses to exercise. (1988) (13)
Crystallization and X-ray investigation of vitamin D-binding protein from human serum. Identification of the crystal content (1995) (12)
The biological roles of vitamin D (1989) (12)
Induction of mixed bone marrow chimerism as potential therapy for autoimmune (type I) diabetes: experience in the NOD model. (1995) (12)
Estrogen deficiency in men is a challenge for both the hypothalamus and pituitary. (2000) (12)
Analogs of calcitriol (2011) (12)
Dietary calcium and phosphate restriction in guinea-pigs during pregnancy: fetal mineralization induces maternal hypocalcaemia despite increased 1α,25-dihydroxycholecalciferol concentrations (2000) (12)
Spontaneous reestablishment of self-tolerance in BB/Pfd rats. (1994) (12)
Synthesis, Structure, and Biological Activity of des‐Side Chain Analogues of 1α,25‐Dihydroxyvitamin D3 with Substituents at C18 (2011) (12)
Results obtained in 75 patients operated upon for hyperparathyroidism: low cholesterol levels in overt primary hyperparathyroidism. (1973) (12)
1,25‐Dihydroxyvitamin D3 induction of the tissue‐type plasminogen activator gene is mediated through its multihormone‐responsive enhancer (1999) (12)
Erythrocyte cation transport systems and membrane lipids in insulin-dependent diabetes. (1993) (12)
The past 10 years—new hormones, new functions, new endocrine organs (2015) (12)
Parathyroid hormone-stimulated calcium absorption in cTAL from vitamin D-deficient rabbits. (1987) (12)
Present Status and Future Strategy for Medical Research in Europe (2007) (12)
35th Annual meeting of the European Association for the Study of Diabetes. Brussels, Belgium, 28 September-2 October, 1999. Abstracts. (1999) (11)
Total, Bioavailable, and Free 25(OH)D Relationship with Indices of Bone Health in Elderly: A Randomized Controlled Trial. (2020) (11)
Effects of diabetes and insulin on bone metabolism (1996) (11)
Nonclassical Effects of 1α,25-Dihydroxyvitamin D3 and Its Analogs (1999) (11)
Vitamin D supplementation and musculoskeletal health. (2019) (11)
Optimal vitamin D supplementation strategies (2017) (11)
Growth without growth hormone receptor: Estradiol is a major growth-hormone independent regulator of hepatic insulin-like growth factor-I synthesis (2004) (11)
Islet xenograft destruction in the hu‐PBL‐severe combined immunodeficient (SCID) mouse necessitates anti‐CD3 preactivation of human immune cells (2000) (11)
Effects of vitamin D-binding protein on bone resorption stimulated by 1,25 dihydroxyvitamin D3 (1990) (11)
Effect of restoration of 25OHD3 status in prolonged critical illness on serum innate immunity parameters LL-37 and sCD163 (2010) (11)
Second antibody chemically linked to cellulose for the separation of bound and free hormone: an improvement over soluble second antibody in gonadotrophin radioimmunoassay. (1976) (11)
Biochemical and density assessment of the new bone in late remodeling after callus distraction (1997) (11)
Safety of high dose vitamin D supplementation. (2019) (11)
Vitamin D-binding protein in pisces (1988) (10)
1 , 25-Dihydroxyvitamin D 3 Influences Cellular Homocysteine Levels in Murine Preosteoblastic MC 3 T 3E 1 Cells by Direct Regulation of Cystathionine b-Synthase (2011) (10)
Intensive insulin therapy in critically ill patients - Reply (2002) (10)
Osteodystrophy of dialysed patients treated with vitamin D. (1973) (10)
Subject Index Vol. 60, Suppl. 3, 2003 (2003) (10)
Immunomodulatory properties of a 1,25(OH)(2) vitamin D(3) analog combined with IFNbeta in an animal model of syngeneic islet transplantation. (2001) (10)
Tumour-induced rickets: A case report and review of the literature (1995) (10)
Plasma vitamin D-binding protein and free 1,25-dihydroxyvitamin D3 index in pregnant ewes and their fetuses in the last month of gestation. (1987) (10)
The IOM–Endocrine Society Controversy on Recommended Vitamin D Targets (2018) (10)
Microarray analysis of MCF-7 breast cancer cells treated with 1,25-dihydroxyvitamin D3 or a 17-methyl-D-ring analog. (2009) (10)
Aggressive pituitary macroadenoma: CT and MR appearances. (1996) (10)
Calcifediol (25OH Vitamin D3) Deficiency: A Risk Factor from Early to Old Age (2022) (10)
Diagnostic fine-needle aspiration cytology and immunocytochemistry analysis of a primary thyroid lymphoma presenting as an anatomic emergency. (2002) (10)
Association of particular HLA class II alleles, haplotypes and genotypes with susceptibility to IDDM in the Belgian population (1994) (10)
How to Define Optimal Vitamin D Status (2011) (10)
Autosomal dominant hypophosphataemia with elevated serum 1,25 dihydroxyvitamin D and hypercalciuria (2004) (10)
Lack of disease recurrence in diabetic BB/Pfd rats after syngeneic islet transplantation. (1993) (10)
Does a better vitamin D status help to reduce cardiovascular risks and events? (2014) (10)
Increased and decreased relative risk for noninsulin‐dependent diabetes mellitus conferred by HLA class II and by CD4 alleles (1995) (9)
Transcortin and vitamin D-binding protein levels in mouse serum. (1986) (9)
Osteocalcin is vitamin D-dependent during the perinatal period in the rat. (1990) (9)
Vitamin D: Giveth to Those Who Needeth (2019) (9)
[Hypothalamic hypopituitarism with hyperphagia and subacute dementia due to neurosarcoidosis: case report and literature review]. (1992) (9)
Daily follow-up of serum parathyroid hormone and calcium after surgery for primary hyperparathyroidism. (1999) (9)
Calcitriol corrects deficient calcitonin secretion in the vitamin D‐deficient elderly (1994) (9)
Public investment in biomedical research in Europe (2015) (9)
A new missense mutation in the CASR gene in familial interstitial lung disease with hypocalciuric hypercalcemia and defective granulocyte function. (2008) (9)
The white adipose tissue connection with calcium and bone homeostasis (2010) (9)
Physiology and pathophysiology of vitamin D-binding protein (1986) (9)
Distribution of group-specific component/vitamin-D-binding protein subtypes in Saudi Arabia. (1991) (9)
Renal responses to calcium deprivation in young rabbits. (1988) (9)
Vitamin D Endocrine System and COVID‐19 (2021) (9)
Improved Risk Assessment for Insulin-Dependent Diabetes mellitus by Analysis of Amino Acids in HLA-DQ and DRB1 Loci (1994) (9)
Antiproliferative and calcemic actions of trans-decalin CD-ring analogs of 1,25-dihydroxyvitamin D3. (2009) (8)
Novel A-ring homodimeric C-3-carbamate analogues of 1alpha,25-dihydroxyvitamin D3: synthesis and preliminary biological evaluation. (2006) (8)
Lack of effect of the vitamin D status on the concentration of the vitamin D-binding protein in rat serum. (1980) (8)
Short-term course of 1,25(OH)2D3 stimulates osteoblasts but not osteoclasts in osteoporosis and osteoarthritis (1991) (8)
Radioimmunoassay for human serum parathyroid hormone. Methods and clinical evaluation (1974) (8)
Synthesis and biological evaluation of 23-oxa-, 23-thia- and 23-oxa-24-oxo-1α,25-dihydroxyvitamin D3 (1993) (8)
Clinical use of vitamin D metabolite assays (calcidiol and calcitriol) (1990) (8)
Plasma 1,25 dihydroxycholecalciferol and its free index are potentiated by ovulation dependent factors and shell formation induced hypocalcemia in the laying hens. (1992) (8)
Interleukin-1 receptor antagonist inhibits primary non-function and prolongs graft survival time of xenogeneic islets transplanted in spontaneously diabetic autoimmune NOD mice (2002) (8)
Physiology of Calcium Homeostasis and Bone Remodeling (2004) (8)
Purification of the serum vitamin D-binding protein (DBP) from different species (1986) (8)
CLINICAL-STUDY OF TICLOPIDINE IN DIABETIC-RETINOPATHY. (1992) (8)
Cultured fibroblasts produce non-active vitamin D metabolites that can be activated by cultured keratinocytes (2003) (8)
Fourteenth Workshop on Vitamin D (2010) (8)
The inherited association of interstitial lung disease, hypocalciuric hypercalcemia, and defective granulocyte function. (1985) (8)
Biological evaluation of epoxy analogs of 1α,25-dihydroxyvitamin D3 (1995) (8)
Renal cadaveric transplantation after total lymphoid irradiation in patients with diabetes. (1983) (8)
Biological activity and conformational analysis of C20 and C14 epimers of CD-ring modified trans-decalin 1α,25-dihydroxyvitamin D analogs (2004) (8)
Diagnosis of Asymptomatic Primary Hyperparathyroidism : Proceedings of the Society (2009) (8)
Hypervitaminosis D Associated With Tanning Bed Use: A Case Report (2017) (7)
Differential responses of plasma aldosterone, cortisol and adrenocorticotropin to two dopamine receptor antagonists. (1985) (7)
The Power of Mass Spectroscopy as Arbiter for Immunoassays. (2016) (7)
Renal transplantation in diabetes after total lymphoid irradiation (TLI) (1983) (7)
Effects of IGF-I, alone and in combination with 17 beta-oestradiol, on bone remodelling parameters in ovariectomised rats. (1995) (7)
Sex steroids during bone growth: a comparative study between mouse models for hypogonadal and senile osteoporosis (2009) (7)
The Vitamin D-Binding Protein (2018) (7)
Protection against autoimmune diabetes by induction of mixed bone marrow chimerism. (1993) (7)
Serum osteocalcin concentrations in diabetic pregnant women and their newborns. (1994) (7)
Development of Analogues of 1α,25-Dihydroxyvitamin D3 with Biased Side-Chain Orientation: C20 Methylated Des-C,D-homo Analogues† (2009) (7)
Serum β-2 microglobulin is a marker of high bone remodelling in elderly women (1998) (7)
Studies on the mode of action of calciferol: comparison of the biochemical properties of an antiserum and the chick intestinal receptor both specific for 1,25-dihydroxyvitamin D3. (1982) (6)
Evidence-based medicine, or how to apply results of clinical trials to patient care (2006) (6)
Monoclonal antibodies to human vitamin D-binding protein. (1985) (6)
Synthesis of CD-ring modified 1α,25-dihydroxy vitamin D analogues: Five-membered D-ring analogues (1997) (6)
UK's NHS trauma systems: lessons from military experience (2010) (6)
Chemoenzymatic synthesis and biological evaluation of C-3 carbamate analogues of 1alpha,25-dihydroxyvitamin D3. (2004) (6)
Synthesis and biological evaluation of some 25,26-epoxy-1α,24-dihydroxyvitamin D3 analogues (1993) (6)
Familial hypocalciuric hypercalcaemia--familial benign hypercalcaemia: a review. (1987) (6)
The Future of Endocrinology and the Endocrinologist of the Future (2002) (6)
How Important Is Vitamin D for Calcium Homeostasis During Pregnancy and Lactation? (2018) (6)
A brown tumor after biliopancreatic diversion for severe obesity. (2009) (6)
Vitamin D sensitive rickets in puberty. (1976) (6)
Effect of Intravenous 25OHD Supplementation on Bone Turnover and Inflammation in Prolonged Critically Ill Patients (2020) (6)
Hypercalcaemia in Hodgkin's disease. (1986) (6)
Streptococcal wall component OK432 restores sensitivity of non-obese diabetic (NOD) thymocytes to apoptotic signals (2000) (6)
Intestinal-Specific Vitamin D Receptor Null Mice Maintain Normal Calcemia but Display Severe Bone Loss (2008) (6)
Crystallization and preliminary X-ray analysis of the vitamin D-binding protein from human serum. (1985) (6)
Renal cadaveric transplantation in diabetics using total lymphoid irradiation or cyclosporin A: A controlled randomized study (1988) (6)
Vitamin D and bone and beyond (2018) (6)
Actions of Insulin and the IGFs on Bone (1994) (6)
Report on recent vitamin D research: ECTS 2012 and the 15th Vitamin D workshop 2012 (2012) (6)
Renal responses to phosphorus deprivation in young rabbits. (1988) (6)
Vitamin D-binding protein and free 1,25-dihydroxyvitamin D in animals and clinical medicine (1985) (6)
Deletion of the Oxygen-sensor PHD2 in Chondrocytes Results in Increased Cartilage and Bone Mineralization (2008) (5)
Activity of vitamin D analogs in co-transfected cos-7 cells (1994) (5)
Asymptomatic primary hyperparathyroidism. (1996) (5)
High Doses Of Vitamin D For The Treatment Of COPD Exacerbations: An Intervention Trial (2011) (5)
Immunomodulatory effects of 1,25(OH)2D3 and its analogues: mechanisms of action and possible clinical application (1997) (5)
Optimizing the Benefits of Bisphosphonates in Osteoporosis (2006) (5)
The effect of microgravity on 1,25-dihydroxyvitamin d3 signalling in osteoblasts (2007) (5)
Radioimmunoassay for Parathyrin. Characterization of Six Different Antigens and Antisera (1978) (5)
Real world evidence of calcifediol use and mortality rate of COVID-19 hospitalized in a large cohort of 16,401 Andalusian patients (2021) (5)
1α-Hydroxy D 3 with and without oestrogen in the treatment of osteoporosis (1981) (5)
TOTAL LYMPHOID IRRADIATION IN RENAL CADAVERIC TRANSPLANTATION IN DIABETICS (1985) (5)
New Aspects of DBP (2005) (5)
Vitamin D3: Synthesis of seco C-9,11,21-trisnor-17-Methyl-1α,25-dihydroxyvitamin D3 Analogues. (2002) (5)
Synthesis of CD‐Ring Modified 1α,25‐Dihydroxy Vitamin D Analogues: C‐Ring Analogues. (1996) (5)
Hormonal and biochemical changes in patients successfully operated for primary hyperparathyroidism. (1976) (5)
How much vitamin D is needed for healthy bones? (2017) (5)
Decreased serum 1,25-dihydroxyvitamin D in diabetes: possible role of vitamin D-binding protein (1985) (4)
Radiogrammetry of the soft tissue at the index finger in acromegaly. (1979) (4)
Comparative analysis of nutritional guidelines for vitamin (2017) (4)
Removal of C-ring from the CD-ring skeleton of 1alpha,25-dihydroxyvitamin D3 does not alter its target tissue metabolism significantly. (2007) (4)
Renal cadaveric transplantation in diabetics using total lymphoid irradiation or cyclosporin A (1988) (4)
Perinatal vitamin D metabolism. (1982) (4)
Primary hyperparathyroidism: pathophysiology, diagnosis and indications for surgery. (2001) (4)
Vanadate potentiates the glycogenic action of insulin‐like growth factors on isolated diaphragm (1992) (4)
Pituitary tumours and bone (1998) (4)
Can vitamin D prevent falls and fractures? (2017) (4)
Insulin and pentastarch for severe sepsis. (2008) (4)
Potentialisation of vitamin D (analogs) by cytochrome P-450 enzyme inhibitors is analog- and cell-type specific (1994) (4)
Vitamin D deficiency and hip fractures: cause or coincidence? (1984) (4)
Versatile synthesis and biological evaluation of 1,3-diamino-substituted 1alpha,25-dihydroxyvitamin D3 analogues. (2006) (4)
Nutritional rickets: calcium or vitamin D deficiency? (2021) (4)
Pheochromocytoma and Hyperparathyroidism (1974) (4)
Serum beta-2 microglobulin is a marker of high bone remodelling in elderly women. (1998) (4)
Bone resorption induced by 1 alpha,25 dihydroxyvitamin D(3) in vivo is not altered by inactivation of the plasminogen activator inhibitor 1. (2000) (4)
Calciotrophic hormones during experimental hypocalcaemia and hypercalcaemia in spontaneously diabetic rats. (1999) (4)
Vitamin D in the older population: a consensus statement (2022) (4)
Ageing men with insufficient vitamin D have a higher mortality risk: no added value of its free fractions or active form. (2021) (4)
1,25-Dihydroxyvitamin D3 reduced MHC-antigen expression on pancreatic β-cells in vitro (1996) (4)
Relationship of total and free 25-hydroxyvitamin D to biomarkers and metabolic indices in healthy children. (2019) (4)
Loss of the vitamin D receptor in the intestine induces severe bone loss to preserve normal calcemia (2008) (4)
Cadaveric kidney transplantation in diabetics after total lymphoid irradiation (TLI). (1984) (4)
Vitamin D and Primary Hyperparathyroidism (2015) (4)
Transcortin activity as related to the age at discovery of diabetes mellitus. (1970) (3)
Vitamin D(3): synthesis of seco-C-9,11-bisnor-17-methyl-1 alpha,25-dihydroxyvitamin D(3) analogues. (2002) (3)
Perturbed Insulin-like Growth Factor-1 (IGF-1) and IGF Binding Protein-3 Are Not Associated with Chronic Widespread Pain in Men: Results from the European Male Ageing Study (2009) (3)
Measuring Vitamin D3 Metabolic Status, Comparison between Vitamin D Deficient and Sufficient Individuals (2022) (3)
Effects of Diabetes and Insulin on Bone Physiology (2008) (3)
CHAPTER 25 – Intestinal Calcium Absorption: Lessons from Knockout Mice and Men (2005) (3)
Vitamin D and the skeleton (2018) (3)
Regulation of calbindin-D28K and its mRNA in the duodenum of the domestic hens (1988) (3)
Leflunomide and its analogue X920715 synergize with cyclosporin A in preventing early graft failure and delaying graft rejection of xenogeneic islets in nonobese diabetic mice. (2001) (3)
Characteristics of the vitamin D binding protein in different species (1975) (3)
Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: cis-perhydrindane CE-ring analogues. (2004) (3)
Calcium and bone homeostasis in diabetic BB rats (1986) (3)
Highlights from the 18th workshop on vitamin D, Delft, The Netherlands, April 21–24, 2015 (2016) (3)
Rickets and Osteomalacia (2018) (3)
Familial pulmonary fibrosis with hypocalciuric hypercalcemia (1979) (3)
Calcium metabolism in the BB rat (1986) (3)
CHAPTER 18 – The Vitamin D Hormone and its Nuclear Receptor: Mechanisms Involved in Bone Biology (2006) (3)
Hypercalcaemia In Hodgkjn’S Disease (1986) (3)
Differences in exposure to stimulatory and inhibitory components of the insulin-like growth factor (IGF) system in patients with femoral neck versus trochanteric fracture. (2005) (3)
Binding protein for vitamin D and its metabolites in rat mesenteric lymph. (1985) (3)
Erythrocyte sodium‐lithium countertransport in insulin‐dependent diabetics: correlation with membrane lipids, prorenin and micro‐albuminuria (1993) (3)
Percutaneous transhepatic venous sampling of the pancreas in localizing insulinomas. (1990) (3)
35th Annual Meeting of the European Association for the Study of Diabetes (2016) (3)
Vitamin D and the kidney: a short review. (1988) (3)
Chapter 24. Gonadal Steroids (2009) (3)
Anabolic effects of testosterone on bone require the presence of a functional androgen receptor in male mice (2002) (3)
How effective is nutritional supplementation for the prevention of stress fractures in female military recruits? (2008) (3)
7-84 PTH or aluminum antagonism in the resistance of uremic bone to the remodeling effect of endogenous PTH? (2001) (2)
Differentiation of human osteoblastic cells (MG-63) in vitro is decreased under microgravity conditions (1996) (2)
[Study of neonatal malnutrition risk in the Zaire milieu]. (1996) (2)
Subpharmacological concentrations of retinoic acid attenuate the anti-proliferative effect of calcitriol on cultured human keratinocytes (abstract) (1995) (2)
Cells metabolizing vitamin D. (1984) (2)
Morning glory syndrome and basal encephalocele mimicking a pituitary adenoma. (1987) (2)
Androgens versus Estrogens: different theories about opposing actions on periosteal bone expansion (2008) (2)
Parathyroid hormone secretion and 25-hydroxyvitamin D levels in primary osteoporosis (1976) (2)
WY 1048, a 17-methyl 19-nor D-ring analog of vitamin D3, in combination with risedronate restores bone mass in a mouse model of postmenopausal osteoporosis (2019) (2)
Clinical applications and technical aspects of parathyroid hormone measurements. (1978) (2)
Rickets in transgenic animals. (2003) (2)
The development of CD-ring modified analogs of 1alpha,25-dihydroxyvitamin D. (2007) (2)
Short-term effects of androgen deficiency and hormonal substitution on serum calcium homeostasis, vitamin D, NcAMP and serum osteocalcin in aged male rats (1991) (2)
Lifelong hypopituitarism and growth hormone deficiency decreases bone size but not volumetric density yet increases prevalence of fractures (2001) (2)
The sunshine hormone vitamin D and its association with type 1 diabetes. (2005) (2)
Vitamin D metabolites in human pregnancy (1983) (2)
Non-classical actions of the vitamin D endocrine system (2007) (2)
P5-05-01: Vitamin D Status in Newly Diagnosed Breast Cancer Patients Inversely Correlates with Tumor Size and Moderately Correlates with Outcome. (2011) (2)
Idiopathic Hypercalciuria: Proposal for a New Cascade (1991) (2)
Intensive insulin therapy in the medical ICU - Reply (2006) (2)
Erratum to “Vitamin D3: Synthesis of seco C-9,11,21-trisnor-17-Methyl-1α,25-dihydroxyvitamin D3 Analogues” [Bioorg. Med. Chem. Lett. 12 (2002) 1629]☆ (2002) (2)
Anabolic and anti-catabolic effects of nandrolone decanoate (Deca-Durabolin) on bone of ovariectomized rats (1990) (2)
Meeting report from the 24th annual meeting of the American society for bone and mineral research (2002) (2)
96 – Animal Models for Gender-Based Skeletal Differences (2004) (2)
Hypercalcemia: increasing diagnostic possibilities to cope with an increasing list of etiologies. (1985) (2)
Hyperthyroxinemia: a cause for hyperemesis gravidarum? (1983) (2)
25-OHD response to vitamin D supplementation in children: effect of dose but not GC haplotype. (2021) (2)
Synthesis, biological activity, and conformational analysis of CD-ring modified trans-decalin 1α,25-dihydroxyvitamin D analogsElectronic supplementary information (ESI) available: Further experimental details. See http://www.rsc.org/suppdata/ob/b2/b209147j/ (2003) (2)
REGULATION OF CYSTATHIONINE BETA SYNTHASE BY 1α,25-DIHYDROXYVITAMIN D3 (2010) (2)
Synthesis and biological activity of 22-oxa CD-ring modified analogues of 1alpha,25-dihydroxyvitamin D3: spiro[5.5]undecane CF-ring analogues. (2004) (2)
Bone Cell Biology in Microgravity (2007) (2)
Erythrocyte cation transport systems in insulin-dependent diabetics: correlation with prorenin and albuminuria. (1994) (2)
Crystallization and preliminary X-ray investigation of the human vitamin D binding protein in complex with 25-hydroxyvitamin D3 (2000) (2)
Dwarfism and Osteopenia in Mice with Inactivated Hypoxia-Response Element in the VEGF Gene Promoter (2008) (2)
Low 25-hydroxyvitamin d3 serum levels are associated with larger breast tumor size (2011) (2)
Vitamin D and cancer (2013) (2)
GH and Bone (1998) (2)
Effects of growth hormone therapy on bone metabolism in patients with adult-onset : a 2-year open randomized controlled multicentre trial (1999) (1)
Two 25-hydroxycholecalciferol-binding proteins in carp serum (1988) (1)
La forza del quadricipite femorale è inversamente correlata all'infiam- mazione sistemica nella BPCO Quadriceps Force Is Negatively Related to Systemic Inflammation in COPD (2003) (1)
Interaction of retinoic acid and 1,25-dihydroxyvitamin D3 on the proliferation of normal human epidermal keratinocytes (abstract) (1996) (1)
Lack of In vitro evidence for storage of 1,25-dihydroxycholecalciferol (1,25(OH)2D3) and 1,25(OH)2D3 binding protein in skeletal matrix (1996) (1)
Textiloma-Induced 1,25-Dihydroxyvitamin D–Mediated Hypercalcemia: A Case Report and Literature Study (2019) (1)
Binding Gene . and Correlates with Variants in the Vitamin D Vitamin D Deficiency is Highly Prevalent in COPD (2009) (1)
Highlights from the 19th Workshop on Vitamin D in Boston, March 29–31, 2016 (2017) (1)
Novel class II HLA-DRB4 and DPB1 alleles found in the Belgian population (2004) (1)
Vitamin D: Classical and Novel Actions Preface (2011) (1)
Vitamin D and Bone Health: Basic and Clinical Aspects (2020) (1)
Vitamin D regulates serum calcium by inhibiting skeletal calcium deposition (2011) (1)
Bone: Which model to predict fracture risk? (2014) (1)
The Vitamin D Workshop 2004 - Preface (2005) (1)
Synthesis of 2‐Methyl and Ethyl‐Substituted 19‐nor‐1α,25‐Dihydroxyvitamin D3 Analogues via the Cyclovitamin Strategy (2005) (1)
Recent data on the relation between certain pathological conditions and steroid carrier activity. (1969) (1)
Vitamin D supplementation and musculoskeletal health. A controversial necessity. (2019) (1)
Measurement of vitamin D-binding protein by immunological and binding techniques (1986) (1)
Vitamin D Deficiency Correlates With Disease Severity In COPD (2010) (1)
Influence of vitamin D treatment on serum levels of parathyroid hormone fragments in patients with chronic renal failure (1975) (1)
Development and applications of a radioimmunoassay for 1,25- dihydroxyvitamin D 3 (1980) (1)
[Vitamin D metabolism in the elderly. Evidence of appropriate synthesis of 1,25 (OH)2 D3]. (1989) (1)
Nonclassical effects of 1alpha,25-dihydroxyvitamin D(3) and its analogs. (1999) (1)
Highlights from the 20th Workshop on Vitamin D in Orlando, Mar. 28–31, 2017 (2017) (1)
Growth hormone and osteoporosis (1974) (1)
Anterior pituitary function in prolonged critical illness: effects of continuous infusion of growth hormone secretagogues (1997) (1)
Effect of sex hormones on apoptosis in NOD mice: Link to autoimmunity (1998) (1)
Treatment of hyperthyroidism with radioactive iodine ( 131 I): the experience of the University Hospitals KU Leuven (1997) (1)
Vitamin D(3): synthesis of seco C-9,11,21-trisnor-17-methyl-1 alpha, 25-dihydroxyvitamin D(3) analogues. (2002) (1)
Increased fetuin-A levels following treatment with a vitamin D analog REPLY (2010) (1)
Vitamin D metabolism and transport (1987) (1)
Cell adhesion, cytoskeletal integrity and growth factors coordinately control vitamin D receptor expression in normal human keratinocytes (1998) (1)
311 Bone mineral status and bone turnover in ambulant children with Duchenne muscular dystrophy (1999) (1)
Age-Associated Endocrine Deficiencies and Muscle Function in Elderly Women - A Cross-Sectional Study (1997) (1)
On transcalciferin, the serum binding protein for 25-hydroxycholecalciferol (1977) (1)
Vitamin D analogues: pharmacology and therapeutic uses (2005) (1)
In memoriam: AW Norman, the founding father of the vitamin D workshops (2020) (1)
Aberrant bone formation in mice over-expressing specific VEGF isoforms in cartilage (2005) (1)
Subject Index, Vol. 16, 1982 (1982) (1)
A novel homozygous inactivating mutation, Pro339Thr, of the calcium-sensing receptor is associated with isolated primary hyperparathyroidism (2007) (1)
In memoriam: AW Norman, the founding father of the vitamin D workshops. (2020) (1)
Clinical significance of transcortin (1985) (1)
Osteoporosis resulting from deficient acquisition of peak bone mass: The SAMP6 mouse model (2004) (1)
Risk of neonatal malnutrition in Zaire (1996) (1)
The biological activity of 23-oxa-, 23-oxa-24-oxo-, and 23-thia-dihydroxyvitamin D3 (1994) (1)
UK Nutrition Research Partnership 'Hot Topic' workshop: Vitamin D-A multi-disciplinary approach to (1) elucidate its role in human health and (2) develop strategies to improve vitamin D status in the UK population. (2022) (1)
Osteoblast function is suppressed by oral methylprednisolone but not by budesonide CIR in active ileocolonic Crohn's disease (1996) (1)
Estrogen stimulates periosteal expansion in male mice, even in the context of depressed systemic levels of insulin-like growth factor-1 (2004) (1)
Vitamin D: the past, the present and the future (1993) (1)
Terminal differentiation of human leukemia cells (HL60) by a combination of 1,25-dihydroxyvitamin D 3 and retinoic acid (all trans or 9-cis) (1994) (1)
Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness (vol 140, pg 17, 1999) (1999) (1)
Fifteenth Vitamin D Workshop (2013) (1)
Fetal hypervitaminosis D results in neonatal lethality (2007) (1)
Comparison of calcifediol with vitamin D for prevention or cure of vitamin D deficiency (2023) (1)
Vitamin D : proceedings of the 12th Workshop on Vitamin D : July 6-10th, 2003, Maastricht, The Netherlands (2004) (1)
Vitamin D and its Metabolites and Analogs in the Management of Osteoporosis (2013) (1)
Introduction: Special Issue on Vitamin D Dedicated to the Memory of Anthony W Norman (2020) (1)
TRPV4 affects bone remodeling by regulating calcium signaling required for osteoclast activity (2007) (1)
Comparative Regulation at the Intestinal and Uterine Level of Calbindin mRNA in the Fowl (1990) (1)
Estrogens prevent the effect of aromatase inhibition on the skeleton of aged male rats (1997) (1)
Prevention of islet graft destruction in diabetic mice and rats by temporary anti-IL-2 receptor therapy: comparison of different strategies. (1998) (1)
The growth plate has an endocrine function: Chondrocytes participate in the interactive loop between FGF23 and 1 alpha, 25-dihydroxyvitamin D-3 (2006) (1)
Vitamin D transport. (1980) (1)
Bijnierincidentaloom. Kost-efficiënte diagnostiek en therapie (1997) (1)
Inhibition of primary non-function and prolongation of graft survival of xenogeneic islets by non-steroidal anti-inflammatory agents in non-obese diabetic mice: correlation with diminished non-T-cell cytokines in the grafts and suppression of plasma nitrite production (2002) (0)
PHD1 and PHD3 are expressed in bone cells but are not essential for bone homeostasis (2007) (0)
Thyroid hormones and antithyroid drugs (1985) (0)
Clinical usefulness of vitamin D metabolite assays (1984) (0)
List of Reviewers 2002–2003 (2003) (0)
New derivatives of vitamin D3 metabolites and application to dosages of vitamin d3 (1988) (0)
Surgery for hypo- and hyperthyroidism. (1987) (0)
Crystal structure of the complex of human vitamin D binding protein and rabbit muscle actin (2003) (0)
Vitamin D3 in Control of Immune Response (2004) (0)
Longitudinal follow-up of androgen action on the skeleton of growing SAMP6 mouse model: No evidence for blunting of action (2005) (0)
Protective effects of vitamin D3 and vitamin D analogues in UVB-irradiated primary keratinocytes (2003) (0)
Vitamin D : a pluripotent steroid hormone : structional studies, molecular endocrinology, and clinical applications : proceedings of the ninth Workshop on Vitamin D, Orlando, Florida (USA), May 28-June 2, 1994 (1994) (0)
Induction of colon cancer cell differentiation by non-steroidal analogs of 1,25-dihydroxyvitamin D-3 (2008) (0)
Phenotype of intestinal-specific VDR knock-out mice (2008) (0)
Free 25-hydroxyvitamin D, but not free 1.25-dihydroxyvitamin D, predicts all-cause mortality in ageing men (2020) (0)
Optimal control of glycemia among critically III patients. Authors' reply (2004) (0)
Assay of vitamin D metabolism and clinical interpretation (1985) (0)
1,25(OH) 2 D 3 and osteocalcin concentrations in fetuses and neonates from rats fed two different calcium-phosphate diets (1988) (0)
Redevelopment of the tolerance to pancreatic B-cells in BB rats (2009) (0)
P19. Etiopathogenesis of UVB stimulated calciuria in chronic gastrointestinal patients with decreased supply of vitamin D (1989) (0)
Crystallization and preliminary x-ray investigation of vitamin D-binding protein from human serum (1994) (0)
The influence of proteoforms: assessing the accuracy of total vitamin D-binding protein quantification by proteolysis and LC-MS/MS (2022) (0)
[Not Available]. (1946) (0)
Disruption of the interferon regulatory factor-1 (IRF-1) pathway renders islets more susceptible to allograft rejection and multiple low-dose streptozotocin-induced diabetes (2000) (0)
Superagonistic action of 14-epi-vitamin D analogs correlates with enhanced vitamin D receptor - coactivator interactions (2005) (0)
The Development of CD-Ring Modified Analogues of 1α,25- Dihydroxyvitamin D (2008) (0)
Ultraviolet light, vitamin D and type 1 diabetes (2010) (0)
Forkhead Box O (FoxO) Transcription Factors in the Actions of 1,25-Dihydroxyvitamin D3 on Osteoblasts (2010) (0)
Abstracts of 16th European Symposium on Calcified Tissues (1981) (0)
Vitamine D et cancer (1994) (0)
Lethal shock in 1,25-dihydroxyvitaminD3 treated NOD mice after HEL immunization (2000) (0)
Synthesis and Biological Activity of 22‐Oxa CD‐Ring Modified Analogues of 1α,25‐Dihydroxyvitamin D3: cis‐Perhydrindane CE‐Ring Analogues. (2004) (0)
Breast Carcinomas − / HER-2 − / Progesterone Receptor − Triple-Negative Estrogen Receptor Is Highly Expressed in Chk 1 The E 2 F-Regulated Gene (2007) (0)
Placental growth factor induces osteoclast differentiation by an autocrine and paracrine pathway (2006) (0)
Serum 1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) in chronic renal failure (CRF): Effect of renal transplantation (RC) (1981) (0)
Development of Analogues of 1α,25‐Dihydroxyvitamin D3 with Biased Side Chain Orientation: Methylated Des‐C,D‐Homo Analogues. (2002) (0)
CHAPTER 71 – Vitamin D and its Metabolites and Analogs in the Management of Osteoporosis (2008) (0)
Meeting Report from the 26th Annual Meeting of the American Society for Bone and Mineral Research: October 1-5, 2004 in Seattle, Washington, USA (2004) (0)
Deficiency osteopathy in a 6-year-old girl with spontaneous fractures and hypoprotidemia. (1946) (0)
Acute Calcium Disorders (2008) (0)
Vitamine D: status anno 1981 (1982) (0)
Influence of two 14-epi-vitamin D3 analogs on the interaction between the vitamin D3 receptor and the coactivator TIF2 (2002) (0)
Retinoic acid modulates the anti-proliferative effect of 1,25-dihydroxyvitamin D-3 in cultured human epidermal keratinocytes (vol 109, 46, 1997) (1997) (0)
The Synthesis of CD-Ring Modified 1α,25-Dihydroxy Vitamin D Analogues: Six-Membered D-Ring Analogues. Part 2. (1997) (0)
In memoriam: Steven Boonen 1962-2013 (2013) (0)
Contents, Vol. 34, 1990 (1990) (0)
Views from Belgium (1997) (0)
[Vitamin D metabolites and their transport in the body]. (1986) (0)
Gs-hypofunction: pseudo(pseudo) hypoparathyroidism (2004) (0)
Subject Index, Vol. 34, 1990 (1990) (0)
Reply to Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women (2022) (0)
Radio immunoassay for parathyrin characterization of 6 different antigens and anti sera (1978) (0)
2-substituted-vitamin D analogs and therapeutic uses thereof (2004) (0)
Are the cytosolic binding proteins for 25-hydroxycholecalciferol artifacts? (1977) (0)
Subject Index Vol. 42, 1996 (1996) (0)
An Appreciation (1959) (0)
Soluble VEGF isoforms are essential to establish epiphyseal vascularization and regulate cartilage development and survival (2003) (0)
Calcifediol or vitamin D to optimize vitamin D status: Reply to letter of M Sosas (2019) (0)
Le peptide C humain: dosage radioimmunologique et applications physiopathologiques (1980) (0)
25-OH-D 3 inhibits calmodulin-activated phosphodiesterase (1985) (0)
CHAPTER 99 – Vitamin D and Diabetes (2005) (0)
The Synthesis of CD-Ring Modified 1α,25-Dihydroxy Vitamin D Analogues: Six-Membered D-Ring Analogues. Part 1. (2010) (0)
Influence of the vitamin D-binding protein on the serum levels of the metabolites of vitamin D (1979) (0)
Book Reviews. (1985) (0)
Androgen action on cortical bone surfaces requires a functional androgen receptor: Evidence from the androgen receptor knock-out mouse model (2005) (0)
Synthesis of CD-Ring Modified 1α,25-Dihydroxy Vitamin D Analogues: E-Ring Analogues. (1996) (0)
Etiopathogenesis of UVB stimulated calciuria in patients with chronic gastrointestinal disorders accompanied with decreased supply of vitamin D (1988) (0)
[Side effects of 131 iodine therapy in hyperthyroidism]. (1984) (0)
Effects of growth hormone (GH) therapy on bone metabolism in patients with adult-onset GH deficiency: A 2-year randomized, controlled trial (2000) (0)
Site-specific cleavages of photoaffinity labelled human vitamin D-binding protein: identification of a 11.5 KDA peptide containing the putative 25-hydroxyvitamin D 3 -binding domain (1991) (0)
Miscellaneous hormones, prostaglandins and releasers (1977) (0)
Reply to ‘The emerging evidence for non-skeletal health benefits of vitamin D supplementation in adults’ (2022) (0)
Witamina D a osteoporoza (1990) (0)
Transcalciferin in serum and cytosol (1976) (0)
Contents Vol. 25, 1999 (1999) (0)
Synergistic immunusuppression by 1,25(OH) 2 D 3 (analogues) and cyclosporin A: animal experiments confirm in vitro data (1994) (0)
Fetal hypomineralization in diabetic rats: Studies on the pathogenesis (1997) (0)
Regulation of semaphorin 3 family members and their receptors by 1α,25-dihydroxyvitamin D3 (2010) (0)
Subject Index Vol. 25, 1999 (1999) (0)
Placental growth factor is a positive regulator of bone remodeling (2005) (0)
Interaction between vitamin D, insulin and diabetes mellitus (1988) (0)
VDR-KO mice have normal insulin secretion in vitro and normal glucose tolerance in vivo (2000) (0)
Determination of vitamin D3 conjugated metabolites: a complementary view on hydroxylated metabolites. (2023) (0)
[Human C-peptide: radioimmunologic assay and physiopathological applications]. (1980) (0)
Immunomodulatory effects of a 14-epi-1,25(OH)2vitamin D3 analog in combination with IFN-β and cyclosporin A in an animal model of syngeneic islet transplantation (2000) (0)
Bone-protecting activity of a new 17-methyl D-ring analog of 1,25(OH)2D3 in primary and secondary prevention mouse model of osteoporosis (2006) (0)
Recent advances in the pathophysiology of the parathyroid glands. (1974) (0)
Unaltered development of insulitis and diabetes in vitamin D receptor KO NOD mice (2006) (0)
Non-steroidal D-ring analogs of 1,25-dihydroxyvitamin D3 are potent inducers of colon cancer differentiation (2007) (0)
Relative role of androgens and estrogens for sexual dimorphism of bone (2005) (0)
[Vitamin D status of the aged subject]. (1987) (0)
Subject Index Vol. 68, 1995 (1995) (0)
Placental growth factor is essential for normal fracture healing in mice by affecting inflammation, angiogenesis and mesenchymal cell development (2004) (0)
The role of radiotherapy in the treatment of thyroid cancer. (1982) (0)
Subject Index Vol. 71, Suppl. 1, 2009 (2009) (0)
Biological activity of CD-ring modified non-steroidal 1α,25(OH)2D3 analogs: E-ring analogs (1997) (0)
Nusap, a gene encoding a tissue-specific protein, use as a diagnostic agent and therapeutic application (2001) (0)
DBP and AIDS: Fact or Fiction? (1988) (0)
Muscle fibre membrane instability in a young boy with an insulinoma. (2001) (0)
Primary hyperparathyroidism and fracture probability (2022) (0)
Trans-decalin previtamin D3 has pronounced genomic activity (2003) (0)
List of Contributors (2020) (0)
Non-Steroidal Analogs (2010) (0)
Relationship between base-line serum insulin-like growth-factor-i and bone-mineral density of the femoral-neck in elderly noninstitutionalized women (1995) (0)
Continuous medical education in endocrinology in Europe. A 1999 European Board of Endocrinology survey. (2000) (0)
Keratinocyte differentiation is accompanied by suppression of vitamin D receptor and induction of retinoid X receptor alpha (1997) (0)
OC12. Specific inhibition of the VEGF homolog placental growth factor is protective against osteolytic bone metastasis in mice (2007) (0)
Deficiency of the plasminogen activators enhances osteoblast proliferation, in vitro mineralization and expression of osteoblast specific markers (2000) (0)
Hypercalcemisch coma en fosfaattherapie (1971) (0)
Estradiol recovers hepatic IGF-I gene expression in growth hormone resistant mice through activation of the JAK-STAT pathway (2005) (0)
Meeting report from the 17th scientific meeting of the international bone and mineral societyJune 24-29, 2007 in Montreal, Quebec, Canada (2007) (0)
Meeting report from the 3rd IFMRS/KU Leuven Herbert Fleisch Workshop, Brugge, Belgium, 17-19 March 2019. (2019) (0)
Space Biology. Cell and Molecular Biology (2001) (0)
[Rickets resistant to calcitropic hormones]. (1995) (0)
Synthesis and Biological Evaluation of 23-Oxa-, 23-Thia-, and 23-Oxa- 24-oxo-1α,25-dihydroxyvitamin D3. (1994) (0)
1,25-dihydroxyvitamin D3 induces growth of thyroid C cells and inhibits calcitonin secretion in vitro (1994) (0)
Prealbumin and mortality 7-84 PTH or aluminum antagonism in the resistance (2001) (0)
Long‐Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial (2023) (0)
Treatment of Renal Osteodystrophy Using Vitamin D or High Dialysate Calcium Concentration (1975) (0)
Comparison of intravenous alfacidol in association with Mg(OH)2 as sole phosphate binder to the association oral CaCO3 +/- Mg(OH)2 in the prevention of hyperparathyroidism in dialysis patients (1991) (0)
Vitamin D deficiency increases type 1 diabetes incidence in NOD mice (2003) (0)
Effects of long-term diabetes or/and high-dose estrogens on bone formation, bone mass and bone strength in the rat (1996) (0)
Calcium homeostasis, bone turnover and bone mass in androgen resistant (testicular feminized) male rats (1992) (0)
Familial Benign Hypercalcemia (1985) (0)
Crystallographic analysis of the human vitamin D binding protein (2002) (0)
Biochemical and functional exploration of the thyroid. (1987) (0)
Down-regulation of DNA replication genes by 1alpha,25-dihydroxyvitamin D3 (2003) (0)
[Basic data on calcium metabolism]. (1973) (0)
Thank you to The LANCET Regional Health - Europe’s clinical and statistical peer reviewers in 2021 (2022) (0)
1,25(OH)2D3 protects against cyclophosphamide-induced diabetes and enhances apoptosis induced by cyclophosphamide (2009) (0)
Introduction to the special issue of BoneKEy Reports on /`vitamin D and bone/' (2014) (0)
[Studies of the cause of increased calciuria in patients with chronic diseases of the digestive system during ultraviolet irradiation of the body to supplement vitamin D deficiency]. (1988) (0)
Effects of bovine bone morphogenetic proteins on osteoclasts in mandibular condyles of neonatal mice in organ culture (1992) (0)
ImmunoradiometricAssay of Parathyrinwith Polyclonaland MonoclonalRegion-Specific Antibodies (1990) (0)
Vitamin D: good or bad for muscle strength? (2021) (0)
Association of vitamin D deficiency with COPD and vitamin D binding proteins (2009) (0)
Effects of 1,25-dihydroxyvitamin D on the DNA replication machinery (2004) (0)
Gene expression profiling in vitamin D-3 treated MC3T3-E1 mouse osteoblasts (2007) (0)
Regulation of cystathione beta synthase by 1alpha,25-dihydroxyvitamin D-3 (2010) (0)
Heterogeneity of human growth in serum. (1974) (0)
Regional assessment of skeletal fluoride kinetics with 18f- - pet in bone disorders (1993) (0)
Vitamin D Binding Gene . COPD and Correlates with Variants in the Vitamin D Deficiency is Highly Prevalent in (2009) (0)
Intestinal calcium transport and bone mineralization in the spontaneously diabetic BB rat (1990) (0)
Reduced Cell Proliferation and Chondrodysplasia in Mice Lacking the Mitotic Protein NuSAP (2008) (0)
Impaired intestinal calcium absorption negatively affects bone mass and mineralization to preserve normocalcemia (2009) (0)
GHRP-2 and TRH infusion for 5 days during protracted, intensive care-dependent critical illness: endocrine and metabolic effects (1998) (0)
Contents, Vol. 16, 1982 (1982) (0)
New structural vitamin d derivatives (1994) (0)
Letter: Pheochromocytoma and hyperparathyroidism. (1974) (0)
Possible mechanisms for the anti-apoptotic action of 1,25-dihydroxyvitamn D3 in primary human keratinocytes (2003) (0)
Chapter 20 – Vitamin D and Bone (2010) (0)
Gc protein clears cellular actin from plasma (1986) (0)
The E2F-Regulated Gene Chk1 Is Highly Expressed in Triple-Negative Estrogen Receptor (cid:1) /Progesterone Receptor (cid:1) /HER-2 (cid:1) Breast Carcinomas (2007) (0)
The effects of 1,25 dihydroxyvitamin D3 on mouse osteoblasts; a cDNA microarray study (2002) (0)
Biological activity of 1,25-dihydroxyvitamin D analogs: influence of relative affinities for DBP and vitamin D receptor (1991) (0)
Systemic IGF-I shows concerted anabolic actions on bone and muscle: Evidence from male mice with liver-specific overexpression of IGF-I (2007) (0)
Rat d diaphragm c contractility a and h histopathology are a affected d differently b by llow d dose ttreatment with m methylprednisolone a and d deflazacort (1995) (0)
Subject Index Vol. 58, Suppl. 1, 2002 (2002) (0)
Vitamin D receptor gene polymorphism influences the amplitude of 1,25(OH)2D3 immune impact (2008) (0)
Muscle fibre membrane instability in a young boy with an insulinoma (2001) (0)
[Treatment of renal osteodystrophy by high doses of vitamin d3]. (1976) (0)
[Quality assurance approval in European health care centers training endocrinology, diabetes and metabolism specialists ]. (1998) (0)
The significance of the free 1,25-dihydroxycholecalciferol concentration (1980) (0)
Calciotropic Hormones and Indices of Bone Turnover in Femoral Neck Osteoporosis (1997) (0)
Vitamin D is a multifunctional hormone (2010) (0)
Vitamine D status van de bejaarde (1987) (0)
Subject Index, Vol. 40, 1993 (1993) (0)
Intestinal calcium absorption regulates serum calcium by compensatory modifications in bone mass and mineralization (2010) (0)
The first IBMS Herbert Fleisch Workshop (2014) (0)
Vitamin D deficiency and prevention; what is the position of European Calcified Tissue Society? (2014) (0)
Thyroid hormones, iodine and antithyroid drugs (1986) (0)
Report on recent vitamin D research (ASBMR 2012) (2013) (0)
Tanning bed-associated hypervitaminosis D in a woman with Paget’s disease and fractures: a case report (2016) (0)
Synthesis and biological evaluation of 1α-hydroxy-25(R and S)-25,26-Epoxy-23-yne vitamin D3 and of 1α,25(R and S),26-Trihydroxy-23-yne vitamin D3 (1997) (0)
List of Reviewers January–November 2015 (2015) (0)
Tuberculous Addison's disease and primary hyperparathyroidism: an unusual combination. (1988) (0)
Vitamin D: Basic and clinical research in vitamin D, vitamin D analogs and bone health (2010) (0)
Studies on antisera against vitamin D-metabolites (1979) (0)
Serum calcium in pre- and post-menopausal women (1979) (0)
Expression of the BRCA1 interacting protein Brip1 is controlled by E2F and correlates with breast cancer malignancy (2008) (0)
Xenogeneic islet graft destruction in the human SCID mouse model can only be achieved by human preactivated immune cells (1999) (0)
The oxygen-sensor PHD2 in chondrocytes modifies bone mass by regulating cartilage collagen processing (2010) (0)
Chondrocytes support osteoclast formation by expressing RANKL, a process controlled by 1 alpha, 25-dihydroxyvitamin D-3 (2005) (0)
Effect of exercise and disuse on bone remodeling, bone mineral density and biomechanical competence in spontaneously diabetic rats (1999) (0)
Effects of growth hormone on bone mass and remodelling in rodents (1997) (0)
Title Pages / Contents (1999) (0)
Anthony W Norman, PhD, Biochemist, Mentor, Distinguished Professor, and Principal Steward of Vitamin D Science (1938–2019) (2019) (0)
Vitamin D Supplementation and Fractures in Adults: A Systematic Umbrella Review (2021) (0)
Diabetes and bone (2020) (0)
The epidermal vitamin D system (2002) (0)
Soluble VEGF isoforms are essential to establish vascularization of cartilage elements and regulate development and survival of growth plate chondrocytes (2003) (0)
Miscellaneous hormones and prostaglandins (1984) (0)
Transcriptional expression of Fas and Fas ligand (FasL) in thymus and spleen of NOD mice (2000) (0)
Androgens, Skeletal Homeostasis, and Osteoporosis (2002) (0)
Enhanced bone mineralization in plasminogen activator-deficient mice (2001) (0)
Second Herbert Fleisch Workshop, 2016 (2016) (0)
Age-dependent changes of vitamin D status and 1,25(OH) 2 D 3 receptor expression in spontaneously hypertensive (SH) rats (1988) (0)
Impact of vitamin D on immune function in diabetes (2005) (0)
Photoprotection and vitamin D status (2019) (0)
Vitamin D3 in control of the immune function (2005) (0)
Microarray analysis of mcf-7 breast cancer cells treated with 1,25-dihydroxyvitamin d-3 or the seco-9,11-bisnor-17-methyl analog wy1112 (2008) (0)
Biological evaluation of epoxy analogs of 1 alpha,25-dihydroxyvitamin D3. (1995) (0)
Influence of vitamin D on the fetal development of the rat (1991) (0)
Vitamin D status of the elderly: clinical usefulness of 25- hydroxyvitamin D assays (1986) (0)
Vitamin D supplementation and musculoskeletal health. A controversial necessity (2019) (0)
Study of IL2 mRNA expression in NOD thymocytes: Effects of in vivo 1,25-dihydroxyvitamin D-3 treatment (2002) (0)
In memoriam Prof. em. Dr. Pieter DE MOOR 1921-1996 (1996) (0)
Severe growth plate abnormalities and increased bone volume in mice with chondrocyte-specific inactivation of Forkhead Box O (FOXO) transcription factors (2011) (0)
Androgenic effects on bone and body composition depend on concerted and additive activation of both AR and ER alpha: Evidence from a new male mouse model with combined disruption of both AR and ER alpha (2007) (0)
Vitamin D action (2006) (0)
Vitamin D is a multifunctional hormone Roger Bouillon Clinic and laboratory of experimental medicine and endocrinology (2012) (0)
[Etiopathogenesis of increased calciuria in patients with chronic diseases of the digestive system and vitamin D deficiency during ultraviolet therapy]. (1988) (0)
Contents Vol. 42, 1999 (1999) (0)
Calcium and vitamin D metabolism in diabetes mellitus (1988) (0)
Hypervitaminosis D inhibits bone matrix mineralization to preserve normocalcemia in mice (2010) (0)
Leptin levels in protracted critical illness: Effects of GH-secretagogues and TRH (1998) (0)
High Dose Vitamin D supplementation alters faecal microbiome and predisposes mice to more severe colitis (2018) (0)
PRIMARY NONFUNCTION OF ISLET XENOGRAFTS IN SPONTANEOUSLY DIABETIC AUTOIMMUNE NOD MICE: CORRELATION WITH ELEVATED NON-T CELL CYTOKINES AND FASL EXPRESSION IN THE GRAFTS. (1999) (0)
Physical Excercise Reduces Remodeling Imbalance and Preserves Trabecular Microarchitecture in Male Mice with Androgen Receptor Disruption (2006) (0)
Both gonadal androgens and peripheral aromatization impact on periosteal growth during puberty in male mice (2006) (0)
Occult ectopic ACTH secretion due to a presumed recurrence of a lung carcinoid: long-term control of hypercortisolism by continuous subcutaneous infusion of octreotide (2001) (0)
Androgens and Skeletal Homeostasis (2003) (0)
Microarray analysis of MCF-7 breast cancer cells treated with 1,25-(OH)(2)D-3 or the analog WY1112 (2008) (0)
Retinoids modulate the anti-proliferative effect of 1,25-dihydroxyvitamin D3 on cultured keratinocytes by affecting the expression of TGF beta1, p21, p27 and RXR alpha (1997) (0)
NO EVIDENCE FOR EXTRARENAL PRODUCTION OF 1,25-DIHYDROXYVITAMIN D IN VITAMIN D-DEFICIENT RATS WITH BCG-INDUCED GRANULOMAS (1991) (0)
GROWTH HORMONE (GH) SECRETION AND GH RESPONSE TO GH-RELEASING PEPTIDE 1 (GHRP-1) IN PUERPERAL WOMEN (1993) (0)
Effect of vitamin-d binding-protein on bone-resorption by 1,25-dihydroxyvitamin-d (1984) (0)
Klinische toepassingen van radioimmunologische TSH-bepalingen (1975) (0)
Insulin antibodies before the administration of insulin in type I diabetes mellitus (1986) (0)
Lessons learned from intestinal VDR-null mice (2009) (0)
[Phosphocalcium metabolism in diabetes mellitus in man and in the BB rat]. (1987) (0)
The hu-PBL-SCID mouse as model for islet xenotransplantation (1999) (0)
A unique pattern of pituitary responsiveness to GHRH, GHRP-2 and TRH in critical illness: indirect evidence of deficiency of the putative endogenous GHRP-like ligand (1996) (0)
Serum parathyroid hormone and calcium during the first days after resection of a parathyroid adenoma. (1998) (0)
Free vitamin D concentrations reflect racial and geographic differences in total 25OHD (2016) (0)
Androgens and skeletal homeostasis in men (1999) (0)
Characterization of the effect of microgravity on gene expression in osteoblasts (2001) (0)
5 The multi-hormone responsive enhancer located far upstream from the human tissue-type plasminogen activator gene confers induction by vitamin D (1997) (0)
Acute effect of shell formation on 1,25 (OH)2D3 and osteocalcin blood levels and on intestinal and uterine calbindin mRNA in hens (1992) (0)
The measurement of 1,25-dihydroxyvitamin D 3 by radioimmunassay (1980) (0)
Diagnosis and Management of Tumors of the Adrenal Gland (1999) (0)
Comparative study of the in vivo action of different doses of 17 beta-estradiol and dihydrotestosterone on bone in an aged male orchidectomized rat model (2001) (0)
Altered bone metabolism in plasminogen activator deficient mice (1997) (0)
Chapter 42 – Effects of Diabetes and Insulin on Bone Physiology (2002) (0)
Vitamin D3 regulates Pdlim2 expression in MCF-7 breast cancer cells (2010) (0)
Vitamin D Effects on Cell Differentiation and Proliferation (2003) (0)
Antagonistic activity of 24-oxa-analogs of vitamin D (1995) (0)
Androgens and skeletal homeostasis. Potential clinical implications of animal data (2002) (0)
Antiproliferative effect of 1,25-dihydroxyvitamin D3 on anaplastic thyroid cancer as a single agent and in combination with paclitaxel and suberoylanilide hydroxamic acid (2010) (0)
[Some endocrinological variations of calcium and phosphorus metabolism]. (1973) (0)
In vitro and in vivo analysis of the immune system of VDR-KO mice (2001) (0)
Primary nonfunction of islet xenografts in spontaneously diabetic autoimmune NOD mice: Correlation with elevated non-T cell cytokines in the grafts (1999) (0)
The transport of vitamin D in man and rat (1978) (0)
Diabetic BB/PFD rats reject MHC incompatible islet grafts, but do not destroy MHC compatible islet grafts. (1994) (0)
Low bone-formation in spontaneously diabetic rats - the role of insulin and adrenal-steroids (1995) (0)
Contents, Vol. 40, 1993 (1993) (0)
Superagonistic 14-epi-vitamin D analogs induce stronger vitamin D receptor – coactivator interactions (2004) (0)
Decreased bone resorption and increased trabecular bone mass in female mice lacking placental growth factor (2003) (0)
The significance of the binding protein for vitamin D in different species. Proc. Sixth Parathyroid Conference, Vancouver (1978) (0)
Hyperthyroidism in Pregnancy (1987) (0)
Free 25-Hydroxyvitamin D : (2016) (0)
Bone and muscle protection and prostate-sparing effects of the selective androgen receptor modulator (SARM) 7 alpha-methyl-19-nortestosterone: Evidence from the aged orchidectomized male rat model (2004) (0)
The epithelial calcium channel (ECaC) is a new candidate for being the rate-limiting step in VDR-dependent active duodenal calcium absorption (2000) (0)
Biological effects of vitamin D: cell differentiation and proliferation (2003) (0)
Contents, Vol. 68, 1995 (1995) (0)
A lytic bone lesion after biliopancreatic bypass surgery for morbid obesity (2003) (0)
GHRP-2 + TRH infusion for 5 days during protracted critical illness: endocrine and metabolic effects (1998) (0)
Trpv6 is important for bone homeostasis during calcium restriction (2009) (0)
Prevention of PNF and prolongation of graft survival in rat islet xenografts in autoimmune NOD mice by a combination of leflunomide and cyclosporine A (1998) (0)
Cooperativity of a 1,25-dihydroxyvitamin D-3 non-steroidal E-ring analog with classical immunosuppressants (1999) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Roger Bouillon?

Roger Bouillon is affiliated with the following schools: